,created,subreddit,text,id,Organizations,Sentiment
44,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
45,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
46,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
47,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
48,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
50,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
52,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
54,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
55,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
57,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
59,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
61,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
62,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
65,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
66,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
67,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
74,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
75,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
76,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
79,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
83,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
85,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
86,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
89,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
92,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
93,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
94,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
95,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
98,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
100,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
104,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
111,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
112,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
114,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
115,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
118,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
121,2021-05-21,wallstreetbets,"YALLA, a fast growing voice centric social media company serving Arabic speaking region, is recently under ferocious short attack from several short sellers. Interestingly, a company that came up with the  report called *Swan Street Research,* didn't have any work before issuing this report. The website was made on the day of this short report. Here is the link and you can see with your own eyes. 

[https://www.swanstreetresearch.com/](https://www.swanstreetresearch.com/)

The report is full of extremely biased and unfounded views, claiming that Yalla's numbers are ""Too good to be true"".

However, anyone with access to the internet can easily find out that Yalla's two major applications: Yalla and Yalla Ludo, consistently rank as top 5 and top 10 highest revenue grossing apps in 20 different countries. Here are some of the top charts attached below. You can also go to [Appannie.com](https://Appannie.com) to get the charts yourself.

You can see Yalla's revenue numbers are consistently higher than HUGE corporations like Tinder, Clash of Clans. In UAE, one of the richest and largest market in the middle east, Yalla has two apps in the top ten on AppStore and it is beating Youtube in terms of revenue. You gotta remember, Yalla is only valued at $2 Billion, a small fraction of the companies they are beating on the revenue chart. (Netflix has a market cap of $222B currently.

Yalla is currently trading at **16 times trailing P/E,** when YoY growth exceeds 221% in Q1. Again, shorts conveniently bypassed easily accessible AppStore revenue ranking and claiming that the numbers are ""Impossible"". In conclusion, if Yalla is valued at 60 times trailing P/E for its 221% growth rate, the company would be easily valued at at least $60 per share. 

These smaller shorts will be PUNISHED for messing with a growth beast like YALLA. Guys, you know what to do next!",nhg4u0,[],1
427,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
428,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
429,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
430,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
431,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
433,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
435,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
437,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
438,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
440,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
442,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
444,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
445,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
448,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
449,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
450,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
457,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
458,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
459,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
462,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
466,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
468,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
469,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
472,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
475,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
476,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
477,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
478,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
481,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
483,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
487,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
494,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
495,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
497,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
498,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
501,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
504,2021-05-21,wallstreetbets,"YALLA, a fast growing voice centric social media company serving Arabic speaking region, is recently under ferocious short attack from several short sellers. Interestingly, a company that came up with the  report called *Swan Street Research,* didn't have any work before issuing this report. The website was made on the day of this short report. Here is the link and you can see with your own eyes. 

[https://www.swanstreetresearch.com/](https://www.swanstreetresearch.com/)

The report is full of extremely biased and unfounded views, claiming that Yalla's numbers are ""Too good to be true"".

However, anyone with access to the internet can easily find out that Yalla's two major applications: Yalla and Yalla Ludo, consistently rank as top 5 and top 10 highest revenue grossing apps in 20 different countries. Here are some of the top charts attached below. You can also go to [Appannie.com](https://Appannie.com) to get the charts yourself.

You can see Yalla's revenue numbers are consistently higher than HUGE corporations like Tinder, Clash of Clans. In UAE, one of the richest and largest market in the middle east, Yalla has two apps in the top ten on AppStore and it is beating Youtube in terms of revenue. You gotta remember, Yalla is only valued at $2 Billion, a small fraction of the companies they are beating on the revenue chart. (Netflix has a market cap of $222B currently.

Yalla is currently trading at **16 times trailing P/E,** when YoY growth exceeds 221% in Q1. Again, shorts conveniently bypassed easily accessible AppStore revenue ranking and claiming that the numbers are ""Impossible"". In conclusion, if Yalla is valued at 60 times trailing P/E for its 221% growth rate, the company would be easily valued at at least $60 per share. 

These smaller shorts will be PUNISHED for messing with a growth beast like YALLA. Guys, you know what to do next!",nhg4u0,[],1
706,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
707,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
709,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
711,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
713,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
714,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
716,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
718,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
720,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
721,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
724,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
725,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
726,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
733,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
734,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
735,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
738,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
742,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
744,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
745,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
748,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
751,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
752,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
753,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
754,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
757,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
759,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
763,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
770,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
771,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
773,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
774,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
777,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
780,2021-05-21,wallstreetbets,"YALLA, a fast growing voice centric social media company serving Arabic speaking region, is recently under ferocious short attack from several short sellers. Interestingly, a company that came up with the  report called *Swan Street Research,* didn't have any work before issuing this report. The website was made on the day of this short report. Here is the link and you can see with your own eyes. 

[https://www.swanstreetresearch.com/](https://www.swanstreetresearch.com/)

The report is full of extremely biased and unfounded views, claiming that Yalla's numbers are ""Too good to be true"".

However, anyone with access to the internet can easily find out that Yalla's two major applications: Yalla and Yalla Ludo, consistently rank as top 5 and top 10 highest revenue grossing apps in 20 different countries. Here are some of the top charts attached below. You can also go to [Appannie.com](https://Appannie.com) to get the charts yourself.

You can see Yalla's revenue numbers are consistently higher than HUGE corporations like Tinder, Clash of Clans. In UAE, one of the richest and largest market in the middle east, Yalla has two apps in the top ten on AppStore and it is beating Youtube in terms of revenue. You gotta remember, Yalla is only valued at $2 Billion, a small fraction of the companies they are beating on the revenue chart. (Netflix has a market cap of $222B currently.

Yalla is currently trading at **16 times trailing P/E,** when YoY growth exceeds 221% in Q1. Again, shorts conveniently bypassed easily accessible AppStore revenue ranking and claiming that the numbers are ""Impossible"". In conclusion, if Yalla is valued at 60 times trailing P/E for its 221% growth rate, the company would be easily valued at at least $60 per share. 

These smaller shorts will be PUNISHED for messing with a growth beast like YALLA. Guys, you know what to do next!",nhg4u0,[],1
782,2021-05-21,wallstreetbets,"I have been following a youtuber and he mentioned how HFs have been destroying companies through their shorting strategies.
It made me think of the simple maths formula.

Suppose we have HFs A, B, C, D
1. Assume A borrows 1 million shares and immediately short them;
2. B buys the same shares and short them;
3. C buys same shares and short them;
4. D buys the same shares and short them

So, 1 million shares have created an additional 3 million shares out of THIN AIR.
Imagine how many times they have done it! There are more than 6,000 stocks traded each day on NYSE and NASDAQ alone.

Like the youtuber said, it is the first time HFs have been caught, GME being the early sign.

The whole market could be Trillions in HOLE!

Now we understand why they work together to manipulate the market.

HOLD and let them sweat! A new market is emerging.",nhgjie,['GME'],0
1159,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
1161,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
1163,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
1164,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
1166,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
1168,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
1170,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
1171,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
1174,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
1175,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
1176,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
1182,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
1183,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
1184,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
1187,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
1191,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
1193,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
1194,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
1197,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
1200,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
1201,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
1202,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
1203,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
1206,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
1208,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
1212,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
1219,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
1220,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
1222,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
1223,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
1226,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
1229,2021-05-21,wallstreetbets,"YALLA, a fast growing voice centric social media company serving Arabic speaking region, is recently under ferocious short attack from several short sellers. Interestingly, a company that came up with the  report called *Swan Street Research,* didn't have any work before issuing this report. The website was made on the day of this short report. Here is the link and you can see with your own eyes. 

[https://www.swanstreetresearch.com/](https://www.swanstreetresearch.com/)

The report is full of extremely biased and unfounded views, claiming that Yalla's numbers are ""Too good to be true"".

However, anyone with access to the internet can easily find out that Yalla's two major applications: Yalla and Yalla Ludo, consistently rank as top 5 and top 10 highest revenue grossing apps in 20 different countries. Here are some of the top charts attached below. You can also go to [Appannie.com](https://Appannie.com) to get the charts yourself.

You can see Yalla's revenue numbers are consistently higher than HUGE corporations like Tinder, Clash of Clans. In UAE, one of the richest and largest market in the middle east, Yalla has two apps in the top ten on AppStore and it is beating Youtube in terms of revenue. You gotta remember, Yalla is only valued at $2 Billion, a small fraction of the companies they are beating on the revenue chart. (Netflix has a market cap of $222B currently.

Yalla is currently trading at **16 times trailing P/E,** when YoY growth exceeds 221% in Q1. Again, shorts conveniently bypassed easily accessible AppStore revenue ranking and claiming that the numbers are ""Impossible"". In conclusion, if Yalla is valued at 60 times trailing P/E for its 221% growth rate, the company would be easily valued at at least $60 per share. 

These smaller shorts will be PUNISHED for messing with a growth beast like YALLA. Guys, you know what to do next!",nhg4u0,[],1
1231,2021-05-21,wallstreetbets,"I have been following a youtuber and he mentioned how HFs have been destroying companies through their shorting strategies.
It made me think of the simple maths formula.

Suppose we have HFs A, B, C, D
1. Assume A borrows 1 million shares and immediately short them;
2. B buys the same shares and short them;
3. C buys same shares and short them;
4. D buys the same shares and short them

So, 1 million shares have created an additional 3 million shares out of THIN AIR.
Imagine how many times they have done it! There are more than 6,000 stocks traded each day on NYSE and NASDAQ alone.

Like the youtuber said, it is the first time HFs have been caught, GME being the early sign.

The whole market could be Trillions in HOLE!

Now we understand why they work together to manipulate the market.

HOLD and let them sweat! A new market is emerging.",nhgjie,['GME'],0
1234,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
2825,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
2827,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
2829,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
2831,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
2832,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
2835,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
2836,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
2837,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
2843,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
2844,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
2845,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
2848,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
2852,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
2854,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
2855,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
2858,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
2861,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
2862,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
2863,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
2864,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
2867,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
2869,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
2873,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
2880,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
2881,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
2883,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
2884,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
2887,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
2893,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
3232,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
3234,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
3235,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
3238,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
3239,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
3240,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
3246,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
3247,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
3248,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
3251,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
3255,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
3257,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
3258,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
3261,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
3264,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
3265,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
3266,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
3267,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
3270,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
3272,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
3276,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
3283,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
3284,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
3286,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
3287,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
3290,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
3296,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
3306,2021-05-21,wallstreetbets,"SEC Gensler Posted to Twitter asking for comments on GME

Which smooth brain apes can comment something meaningful to:

1. Protect Retail Investor interests from HF & Clearing House during a squish 

2. Help the SEC understand Ape position 

3. Logically expose the corruption we face day to day

4. Be like DFV and express we just like the stock

The Tweet is up now - the dudes name is Barry Gensler 

Whereâ€™s our smooth brained apes ðŸ¦- Iâ€™m not smart enough to do it",nhhrk5,['GME'],1
3307,2021-05-21,wallstreetbets,"Since y'all seemed to enjoy my telecom company [analysis](https://www.reddit.com/r/wallstreetbets/comments/n8ok60/fundamental_comps_analysis_for_vz_t_and_tmus_fair/), I thought I would share this one I put together for cruise ship companies. I had a suspicion that because this industry suffered so much during Covid there might be a value opportunity here, but based on my analysis the financials simply don't support that thesis.

With VZ, looking at the financials led me to further efforts: researching the nature of the telecommunications industry, the management team, wall street sentiment, and much more before I eventually purchased for myself (bought @ 55.87!). Here, I have not been nearly as thorough in investigating these intangibles because for me and my portfolio, the financials of these companies are a non-starter. If I had to pick a favourite it would be CCL (LIND for least favourite), but I do not own any of these companies and have no plans to purchase. If you have more info than me and think one or more of these companies are strong buys then tell me! I would love to have my mind changed and make some $$$.

**Model**:

[https://docs.google.com/spreadsheets/d/1bOtF0m9AiS8OLVCeCfISRfiTwQGIGQ1cjWj3goP\_ro4/edit?usp=sharing](https://docs.google.com/spreadsheets/d/1bOtF0m9AiS8OLVCeCfISRfiTwQGIGQ1cjWj3goP_ro4/edit?usp=sharing)

**Methodology**:

* Created a three-statement model for Carnival Corp., Norwegian Cruise Line Holdings Ltd., Royal Caribbean Cruises Ltd., and Lindblad Expeditions Holdings Inc.
* Combined these with a WACC build-up to create an unlevered DCF and derived a fair-value-per-share estimate using a growth in perpetuity and an exit EBITDA multiple approach
* Spread comparable companies (these 4)
* Combined results from DCF and select comps valuations to arrive at final estimates

**How to use the model**

* Anywhere you see blue text is OK to edit, and should not result in breaking anything. Green text = taken from another worksheet, so if you want to change one of those cells I recommend following the trail first
* To make meaningful changes to the 3-statement-model, scroll to the bottom of each ""Financials"" page to tweak assumptions about revenue growth, GPM, and other assumptions. You can also adjust the specifics for each case scenario from here
* I have tried to supply somewhat pessimistic assumptions about terminal growth rates and exit EBITDA multiples in the DCF models. Feel free to adjust as needed, keeping in mind the model is very sensitive to these inputs
* WACC buildup can be done however you want. If you have access to a Bloomberg terminal you can get a better adjusted beta than I used, and a more precise cost of debt (more on that below), or you can just use the override cell to put in a WACC% directly
* Trading Comps Input essentially works to arrive at normalized multiples before converting to an output. Do not be intimidated by non-Gaap disclosures. Everything here is available on annual reports, quarterly reports, and press releases.
* For trading comps outputs, simply toggle the companies in column B until you have the company you wish to analyze in the first position, and the other comps below it, then head to Valuation Matrix to see the results.
* Feel free to adjust the assumptions, there are a lot of them
* If you can think of an assumption better than something I have here, or if you spot a mistake let me know!

**Other Notes:**

* The analyst consensus for revenue increases from 2021 -> 2022 are insanely high, but yes cruises are expected to rebound by that much
* The glaring issue with the comps analysis is that there simply aren't enough of them. I considered including Disney as a sort of look at what these cruise lines would all dream of being one day, but that was too much of a reach. If Disney Cruises released their financials separately that would be a different story, and beyond that I couldn't find any reasonable comps.
* Sadly, the best comparable missing, MSG cruises, is a private company :(
* Super low valuations for RCL and LIND are not mistakes...(unless they are), valuations so separated from fundamentals like this make me think something else is going on (industry consolidation? Upcoming M&A? Who knows)
* I try to be harsh on my fair value estimates to protect myself from making bad buys! Keep that in mind. I only want to put my capital where there is undeniably a value opportunity
* I Imported the model from excel to Google Sheets before sharing, so if something is broken, let me know so I can go in and fix it ASAP
* Used 10Y YTM bond data on FINRA when possible to arrive at assumptions for cost-of-debt used in WACC build-up. If you have access to a bloomberg terminal you can grab the bond with the best volume and use that.
* I apologize for ambiguity (especially on the non-gaap stuff) but I couldn't figure out how to remove my name from the comments quickly (if you know how to do this, other than going one-by-one through each comment, let me know and I'll reupload). Most comments were simply memos to myself to remember what each cell consists of beyond the label (i.e., components of ""other current assets"")
* A thousand more things. If you want to know just ask.

**None of this is financial advice. This is an exercise I did for my own use and thought this sub might find it entertaining.**  
**Do your own Due Diligence.**  
**I do not own any of these stocks.**

Fair Value Price Estimates:  
CCL 26.39  
NCLH 22.71  
RCL 39.31  
LIND 5.37

Stay tuned for my next one: Ecommerce. There are definitely some ecommerce companies I believe in and are worth a greater dive, so that one won't be up for awhile yet.",nhhrmv,[],0
3724,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
3726,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
3728,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
3730,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
3731,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
3734,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
3735,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
3736,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
3742,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
3743,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
3744,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
3747,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
3751,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
3753,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
3754,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
3757,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
3760,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
3761,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
3762,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
3763,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
3766,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
3768,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
3772,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
3779,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
3780,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
3782,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
3783,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
3786,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
3792,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
4782,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
4784,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
4785,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
4788,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
4789,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
4790,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
4796,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
4797,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
4798,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
4801,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
4805,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
4807,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
4808,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
4811,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
4814,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
4815,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
4816,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
4817,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
4820,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
4822,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
4826,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
4833,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
4834,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
4836,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
4837,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
4840,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
4846,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
5250,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
5251,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
5254,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
5255,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
5256,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
5262,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
5263,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
5264,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
5267,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
5271,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
5273,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
5274,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
5277,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
5280,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
5281,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
5282,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
5283,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
5286,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
5288,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
5292,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
5299,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
5300,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
5302,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
5303,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
5306,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
5312,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
5416,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
5417,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
5923,2021-05-19,wallstreetbets,"Alright ladies and gentlemen.... mostly just gentlemen. Hopefully y'all ain't gentle because this time we going HARD! I will be talking about Switch. A company that provides data centers to some of the world's most secure clientele.

  
What is Switch? 

Switch, Inc. (Nevada) engages in the provision of technology infrastructure. It specializes in the development of digital platforms for digital media companies, cloud and managed service providers, financial institutions, and telecommunications providers. The firm's products include Switch CONNECT and Switch SAFE. The company was founded by Rob Roy in 2000 and is headquartered in Las Vegas, NV. The listed name for SWCH is Switch, Inc. Class A Common Stock.

Down below I will keep it simple. Listing Pros and Cons to this company.

Pros:

* Provides data centers to all four major latency zones in America. **The Core Campus** (Southwestern United States), **The Citadel Campus** (Northwestern United States), **The Pyramid Campus** (Northeastern United States), **The Keep Campus**Â (Southeastern United States). [source](https://www.switch.com/locations/)
* Recent acquisition of Data Foundry allows the company to have exposure to Texas based clients and real estate.  
* Security on campus is top notch. Both inside the Data centers and outside. Haven't personally worked with their systems, but they have top notch security systems in place inside their software. (with recent hacks to global infrastructure imo VERY IMPORTANT). Outside they have multiple gates and security keeping close guard of campuses. It is like a well kept fortress of data, a place where you can trust and depend upon for safety. [source](https://www.switch.com/switch-vault/)
* Switch operates by buying data center real estate and being very similar to a REIT. However, since their structuring is different than a REIT they are not required to pay dividends on most of their profits. This allows them to have cash on hand to fund future growth. [source](https://www.datacenterknowledge.com/switch/what-switch-doing-right-ship#:~:text=On%20the%20TRA%20liability%3A%20Switch,liquid)
* Switch is also a huge player for renewable energy. They make a huge point to reduce their carbon impact. They do this with geothermal energy and also Solar. All their campuses have renewables in place. I believe this is important in the sense of being a responsible investor, but renewables also have a great deal of benefits on the cost side of things too. Once Solar panels and geothermal pays for itself you reach a point of profitability on that investment, in turn reducing costs and increasing margins. [source](https://www.switch.com/about/#social-responsibility)
* Client base is huge. Come on... just look at this list. [source](https://www.switch.com/clients/) 
* Financials are pretty aight to me tbh.

Cons:

* As a play on data center real estate. We could see risks in the overall real-estate market that bleed to the stock. 
* Hacks that target Switch can possibly tamper with their reputation.
* Competition from another firm that provides services at a cheaper price or at superior quality. (obviously)
* Not paying dividends might turn off certain investors. Personally I think its more of a pro than a con.
* Rob Roy controlling a majority of the voting power of the company. (Caesar made Rome what it was with complete authority over military. So IMO who cares)
* Shares haven't really gone up. Down 13%.

&#x200B;

Conclusion:

I like the company and believe it has a lot of promise. With how low IV is options look like they are priced well. I wouldn't mind holding shares either. 

Here is some better and more thought out DD:

[https://www.reddit.com/r/investing/comments/84hqui/switch\_swch\_is\_a\_data\_center\_stock\_positioned\_to/](https://www.reddit.com/r/investing/comments/84hqui/switch_swch_is_a_data_center_stock_positioned_to/)

&#x200B;

Position:

$SWCH 25c 1/20/23",ngfajd,[],1
5924,2021-05-19,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngfh4g,[],1
5925,2021-05-19,wallstreetbets,"Some companies have already published a report for the 1st quarter of 2021, thatâ€™s exactly what Iâ€™ve compared. I was comparing the revenue for the 4th quarter of 2020 with the revenue for the 1st quarter of the current year. If you want to see a new top for all companies, regardless of whether their report is up-to-date or not - just hit me up in the comments.

Here we go:

**1.** **$**[LBRDA](https://contora.ai/ticker/lbrda) **(Liberty Broadband Corporation)** is an investment company engaged in communications businesses. Increased by 637%.

[$LBRDA](https://preview.redd.it/6eg1xk7wt4071.png?width=2180&format=png&auto=webp&s=12e9353cba8db91c3373abb2a20b01206f79a5b0)

**2. $**[BGNE](https://contora.ai/ticker/bgne) **(BeiGene Ltd.)** \- the company is engaged in developing a cure for cancer. Increased by 605%.

[$BGNE](https://preview.redd.it/4kc6d9dzt4071.png?width=2174&format=png&auto=webp&s=9e32f0fcab4f821f41d9de9e2328b14b4e7447ff)

**3.** **$**[NRG](https://contora.ai/ticker/nrg) **(NRG Energy Inc.)** \- energy company. Increased by 399%.

[$NRG](https://preview.redd.it/fkzj52y2u4071.png?width=2184&format=png&auto=webp&s=22fd847da60408dbfa76f52d235d8ccac1c7437c)

PS The list also contained companies Codiak BioSciences and Dynavax Technologies, but the bot did not pass them through due to weak capitalization. Although in my opinion, they are the most promising among all mentioned above.

Perhaps this analysis is an obvious thing and many have published it, but maybe someone will find it valuable

Thoughts?",ngfiu9,[],0
5927,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
5928,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
5929,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
5930,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
5931,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
5933,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
5935,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
5937,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
5938,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
5940,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
5942,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
5944,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
5945,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
5948,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
5949,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
5950,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
5956,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
5957,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
5958,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
5961,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
5965,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
5967,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
5968,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
5971,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
5974,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
5975,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
5976,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
5977,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
5980,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
5982,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
5986,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
5993,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
5994,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
5996,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
5997,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
6000,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
6006,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
6015,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
6016,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
6018,2021-05-21,wallstreetbets,"Need Help !!!

Hi guys Iâ€™m new to reddit but Iâ€™ve been following WSB from time. I need some help. Throughout 2020 I made some decent money buying monthly calls on tech stocks (turned $5000 to 25,000 USD). Unfortunately since the market of volatility of 2021 my portfolio is now under $1000 USD. If I ever make big money like that again Iâ€™m going to put a large portion into dividend stocks and/or real estate down payment. I need some help tho I have no job but fortunately I have some security still living with my parents. I still wanna trade options so I can gain some independence and fund my graduate studies this September. Any help, tips, suggestions, strategies, or recommendations for good stocks to play options on would be greatly appreciated!!!",nhituh,[],1
6619,2021-05-19,wallstreetbets,"Alright ladies and gentlemen.... mostly just gentlemen. Hopefully y'all ain't gentle because this time we going HARD! I will be talking about Switch. A company that provides data centers to some of the world's most secure clientele.

  
What is Switch? 

Switch, Inc. (Nevada) engages in the provision of technology infrastructure. It specializes in the development of digital platforms for digital media companies, cloud and managed service providers, financial institutions, and telecommunications providers. The firm's products include Switch CONNECT and Switch SAFE. The company was founded by Rob Roy in 2000 and is headquartered in Las Vegas, NV. The listed name for SWCH is Switch, Inc. Class A Common Stock.

Down below I will keep it simple. Listing Pros and Cons to this company.

Pros:

* Provides data centers to all four major latency zones in America. **The Core Campus** (Southwestern United States), **The Citadel Campus** (Northwestern United States), **The Pyramid Campus** (Northeastern United States), **The Keep Campus**Â (Southeastern United States). [source](https://www.switch.com/locations/)
* Recent acquisition of Data Foundry allows the company to have exposure to Texas based clients and real estate.  
* Security on campus is top notch. Both inside the Data centers and outside. Haven't personally worked with their systems, but they have top notch security systems in place inside their software. (with recent hacks to global infrastructure imo VERY IMPORTANT). Outside they have multiple gates and security keeping close guard of campuses. It is like a well kept fortress of data, a place where you can trust and depend upon for safety. [source](https://www.switch.com/switch-vault/)
* Switch operates by buying data center real estate and being very similar to a REIT. However, since their structuring is different than a REIT they are not required to pay dividends on most of their profits. This allows them to have cash on hand to fund future growth. [source](https://www.datacenterknowledge.com/switch/what-switch-doing-right-ship#:~:text=On%20the%20TRA%20liability%3A%20Switch,liquid)
* Switch is also a huge player for renewable energy. They make a huge point to reduce their carbon impact. They do this with geothermal energy and also Solar. All their campuses have renewables in place. I believe this is important in the sense of being a responsible investor, but renewables also have a great deal of benefits on the cost side of things too. Once Solar panels and geothermal pays for itself you reach a point of profitability on that investment, in turn reducing costs and increasing margins. [source](https://www.switch.com/about/#social-responsibility)
* Client base is huge. Come on... just look at this list. [source](https://www.switch.com/clients/) 
* Financials are pretty aight to me tbh.

Cons:

* As a play on data center real estate. We could see risks in the overall real-estate market that bleed to the stock. 
* Hacks that target Switch can possibly tamper with their reputation.
* Competition from another firm that provides services at a cheaper price or at superior quality. (obviously)
* Not paying dividends might turn off certain investors. Personally I think its more of a pro than a con.
* Rob Roy controlling a majority of the voting power of the company. (Caesar made Rome what it was with complete authority over military. So IMO who cares)
* Shares haven't really gone up. Down 13%.

&#x200B;

Conclusion:

I like the company and believe it has a lot of promise. With how low IV is options look like they are priced well. I wouldn't mind holding shares either. 

Here is some better and more thought out DD:

[https://www.reddit.com/r/investing/comments/84hqui/switch\_swch\_is\_a\_data\_center\_stock\_positioned\_to/](https://www.reddit.com/r/investing/comments/84hqui/switch_swch_is_a_data_center_stock_positioned_to/)

&#x200B;

Position:

$SWCH 25c 1/20/23",ngfajd,[],1
6620,2021-05-19,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngfh4g,[],1
6621,2021-05-19,wallstreetbets,"Some companies have already published a report for the 1st quarter of 2021, thatâ€™s exactly what Iâ€™ve compared. I was comparing the revenue for the 4th quarter of 2020 with the revenue for the 1st quarter of the current year. If you want to see a new top for all companies, regardless of whether their report is up-to-date or not - just hit me up in the comments.

Here we go:

**1.** **$**[LBRDA](https://contora.ai/ticker/lbrda) **(Liberty Broadband Corporation)** is an investment company engaged in communications businesses. Increased by 637%.

[$LBRDA](https://preview.redd.it/6eg1xk7wt4071.png?width=2180&format=png&auto=webp&s=12e9353cba8db91c3373abb2a20b01206f79a5b0)

**2. $**[BGNE](https://contora.ai/ticker/bgne) **(BeiGene Ltd.)** \- the company is engaged in developing a cure for cancer. Increased by 605%.

[$BGNE](https://preview.redd.it/4kc6d9dzt4071.png?width=2174&format=png&auto=webp&s=9e32f0fcab4f821f41d9de9e2328b14b4e7447ff)

**3.** **$**[NRG](https://contora.ai/ticker/nrg) **(NRG Energy Inc.)** \- energy company. Increased by 399%.

[$NRG](https://preview.redd.it/fkzj52y2u4071.png?width=2184&format=png&auto=webp&s=22fd847da60408dbfa76f52d235d8ccac1c7437c)

PS The list also contained companies Codiak BioSciences and Dynavax Technologies, but the bot did not pass them through due to weak capitalization. Although in my opinion, they are the most promising among all mentioned above.

Perhaps this analysis is an obvious thing and many have published it, but maybe someone will find it valuable

Thoughts?",ngfiu9,[],0
6623,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
6624,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
6625,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
6626,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
6627,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
6629,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
6631,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
6633,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
6634,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
6636,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
6638,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
6640,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
6641,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
6644,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
6645,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
6646,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
6652,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
6653,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
6654,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
6657,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
6661,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
6663,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
6664,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
6667,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
6670,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
6671,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
6672,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
6673,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
6676,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
6678,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
6682,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
6689,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
6690,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
6692,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
6693,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
6696,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
6702,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
6711,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
6712,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
7395,2021-05-19,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngfh4g,[],1
7396,2021-05-19,wallstreetbets,"Some companies have already published a report for the 1st quarter of 2021, thatâ€™s exactly what Iâ€™ve compared. I was comparing the revenue for the 4th quarter of 2020 with the revenue for the 1st quarter of the current year. If you want to see a new top for all companies, regardless of whether their report is up-to-date or not - just hit me up in the comments.

Here we go:

**1.** **$**[LBRDA](https://contora.ai/ticker/lbrda) **(Liberty Broadband Corporation)** is an investment company engaged in communications businesses. Increased by 637%.

[$LBRDA](https://preview.redd.it/6eg1xk7wt4071.png?width=2180&format=png&auto=webp&s=12e9353cba8db91c3373abb2a20b01206f79a5b0)

**2. $**[BGNE](https://contora.ai/ticker/bgne) **(BeiGene Ltd.)** \- the company is engaged in developing a cure for cancer. Increased by 605%.

[$BGNE](https://preview.redd.it/4kc6d9dzt4071.png?width=2174&format=png&auto=webp&s=9e32f0fcab4f821f41d9de9e2328b14b4e7447ff)

**3.** **$**[NRG](https://contora.ai/ticker/nrg) **(NRG Energy Inc.)** \- energy company. Increased by 399%.

[$NRG](https://preview.redd.it/fkzj52y2u4071.png?width=2184&format=png&auto=webp&s=22fd847da60408dbfa76f52d235d8ccac1c7437c)

PS The list also contained companies Codiak BioSciences and Dynavax Technologies, but the bot did not pass them through due to weak capitalization. Although in my opinion, they are the most promising among all mentioned above.

Perhaps this analysis is an obvious thing and many have published it, but maybe someone will find it valuable

Thoughts?",ngfiu9,[],0
7398,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
7399,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
7400,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
7401,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
7402,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
7404,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
7406,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
7408,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
7409,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
7411,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
7413,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
7415,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
7416,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
7419,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
7420,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
7421,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
7427,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
7428,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
7429,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
7432,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
7436,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
7438,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
7439,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
7442,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
7445,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
7446,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
7447,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
7448,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
7451,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
7453,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
7457,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
7464,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
7465,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
7467,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
7468,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
7471,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
7477,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
7486,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
7487,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
7489,2021-05-21,wallstreetbets,"This happened roughly 4 hours ago from making this post and the new terms go into effect June 1st. 

I really think this is huge for GOOG/GOOGL ad revenue. According to socialblade, there are 56 million channels under 1k subs(100-999) as of November 13 2020. Youtube previously demonitized smaller channels but I guess is going all in.

From Youtube: ""YouTubeâ€™s right to monetize: YouTube has the right to monetize all content on the platform and ads may appear on videos from channels not in the YouTubeÂ PartnerÂ Program.""

With GOOG's stock rising $600 EPS over the past 6 months and with this, I almost see nothing that can stop tremendous ad revenue and a moderate EPS during Q3 earnings call.",nhj72c,[],0
7491,2021-05-21,wallstreetbets,"If you're still kicking yourself about not putting your entire 401k into Shopify and getting those sweet 40x gains, I think BIGC may be one of the next hot stocks.

Currently BIGC is trading at 17x revenue and I think that a fair value for this stock is 20 to 40x revenue (especially since it will be compared with Shopify). Average growth the past few years per quarter is around 8.4% per quarter.

Currently the stock is down this year trading around $50, peak was $140 last year.

Projecting out growth over 5 years shows that:

1. 2021: Revenue $211M, stock $60 to $120
2. 2022: Revenue $292M, stock $83 to $166
3. 2023: Revenue $403M, stock $114 to $230
4. 2024: Revenue $556M, stock $158 to $316
5. 2025: Revenue $768M, stock $218 to $437
6. 2026: Revenue $1B, stock $302 to $604

Personally I think that as the company continues to show strong growth the share price will grow overvalued in the short term (before EOY). I do think the stock will be a 5 to 10x bagger in the next five years though. They may also be able to hit $1B in revenue sooner than 2026.

TLDR; BIGC good, like SHOP, but undervalued.

Position: 2000 shares @ $55

>!(research is my own and might be garbage. never take advice from strangers)!<",nhjghj,[],1
7492,2021-05-21,wallstreetbets,"So about the rumour that it was a coordinated attack to drop the price down to 30k.. I donâ€™t really understand how a move like that could be pulled off. 

Say you do have endless amounts of money to manipulate the market.. you suddenly sell all the way to push it down to 30k.. but then what? You have to buy it back.. at 30k? Buying a large amount back would surely just push the price back up significantly anyway? Youâ€™re not really making a profit worth the risk if thatâ€™s the case.. And wouldnâ€™t it be harder to buy it back when people are anchored to it going back up to 60k? A move like that just seems unrealistic.",nhji0z,[],0
7808,2021-05-19,wallstreetbets,"Some companies have already published a report for the 1st quarter of 2021, thatâ€™s exactly what Iâ€™ve compared. I was comparing the revenue for the 4th quarter of 2020 with the revenue for the 1st quarter of the current year. If you want to see a new top for all companies, regardless of whether their report is up-to-date or not - just hit me up in the comments.

Here we go:

**1.** **$**[LBRDA](https://contora.ai/ticker/lbrda) **(Liberty Broadband Corporation)** is an investment company engaged in communications businesses. Increased by 637%.

[$LBRDA](https://preview.redd.it/6eg1xk7wt4071.png?width=2180&format=png&auto=webp&s=12e9353cba8db91c3373abb2a20b01206f79a5b0)

**2. $**[BGNE](https://contora.ai/ticker/bgne) **(BeiGene Ltd.)** \- the company is engaged in developing a cure for cancer. Increased by 605%.

[$BGNE](https://preview.redd.it/4kc6d9dzt4071.png?width=2174&format=png&auto=webp&s=9e32f0fcab4f821f41d9de9e2328b14b4e7447ff)

**3.** **$**[NRG](https://contora.ai/ticker/nrg) **(NRG Energy Inc.)** \- energy company. Increased by 399%.

[$NRG](https://preview.redd.it/fkzj52y2u4071.png?width=2184&format=png&auto=webp&s=22fd847da60408dbfa76f52d235d8ccac1c7437c)

PS The list also contained companies Codiak BioSciences and Dynavax Technologies, but the bot did not pass them through due to weak capitalization. Although in my opinion, they are the most promising among all mentioned above.

Perhaps this analysis is an obvious thing and many have published it, but maybe someone will find it valuable

Thoughts?",ngfiu9,[],0
7810,2021-05-19,wallstreetbets," 

## Summary

* 100% technical buy signals.
* 13 new highs and up 14.11% in the last month.
* 222.13% gain in the last year.

[https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands](https://www.barchart.com/story/news/1733045/barchart-com-s-chart-of-the-day-cornerstone-building-brands)

https://preview.redd.it/uza8ykmbx4071.png?width=1219&format=png&auto=webp&s=d2db45939a1645e3a76cd6f232849e0922c945ee",ngfth7,[],0
7811,2021-05-19,wallstreetbets,"Funny, true (albeit sad) story about Jim Cramer.  Can't find it anywhere online, but this did happen and Iâ€™m sure thereâ€™s someone else who also remembers and can corroborate â€“ and with all the un-checked bashing of Jim on this forum, I canâ€™t imagine this post wonâ€™t make the cut, so here goes:  In the early 2000's, Jim hosted a syndicated radio show â€“ think it was ""Real Money"" or similar (well before his TV show).  It ran on our local talk station in the early evenings, and I would listen to every broadcast with rapt attention - not so much for the individual stock picks but I really liked his general philosophy and enthusiasm for investing.  I found the show to be infectious (in a positive way) and did go on to buy at least one of his books which was not a half bad read.  To be fair, I still like his passion, but not necessarily his picks.

Anyway, one night on his radio show, Jim was really pimping his ""special guest"" who would be on in the next hour to discuss investing - it was his wife at the time (I believe it was Karen) and he was building up her appearance in a BIG way.  By the time she got behind the microphones, he was introducing her as the most â€œamazingâ€ woman, ""the goddess of stock-picking"" (really, I remember that phrase like it was yesterday), and she would be on the air to lend us mortals her divine insights into the stock market and we would all be witness to the unequalled inspiration and knowledge that would flow from her lips.

THE WORD 'FAIL' WAS INVENTED THAT EVENING.  After such a build-up with James lapping at her feet and worshipping her as such an amazing financial mind, Jim began to ask her some reasonable, normal questions about her thoughts on the market.  She responded with nothing but recalcitrant short phrases and snippy, one-word answers such as ""well, what do YOU think?"", ""that's hard to tell"", ""I donâ€™t know â€“ why would I know?â€, ""maybe"", ""yes"", ""no"".  This was not her being nervous â€“ it was clear to me that she was sabotaging the show by being recalcitrant, obstinate, and rebellious towards him and not giving so much as an inch of insight.

The word malicious doesnâ€™t even begin to describe her appearance that night.

Despite Jimâ€™s continued groveling at her feet during the interview, it very quickly became clear she was doing her very best to undermine him.  Eventually, you could cut the tension with a knife â€“ and this was over the radio.  Anyway, as my jaw dropped, my heart also sank as I listened to this debacle â€“ I donâ€™t think that I was ever more embarrassed for another human being as I was for Jim on his national radio show that night.

Again, I admire Jimâ€™s enthusiasm and some of his general philosophy, but that episode of his radio show was an absolute fail.  And I donâ€™t blame him, other than perhaps for not vetting his wife and her demeanor toward him before he invited her on his radio show.",ngftx1,[],0
7812,2021-05-19,wallstreetbets,"Ever since the Feb peak, the sell pressure has been high and news pieces coming out one after another to give investors reason to sell. Sector rotation, tech bubble fear, jump in 10-year treasury rate marked the beginning of inflation fear. And mistrust in FED that JPOW will not raise interest rate until at least 2023.

Big tech's earnings absolutely destroyed estimates but sell side thinks it's due to lock down and people will rely on tech less once things open up. It's a consistent pattern that all the gains made after earning erode overnight or in a few trading session as if the good earning did not happen. 

At the same time, the indexes are still hover around all time high. Remember how excited this sub was when SPY edging $400 and we are now still at $410. Meanwhile small growth stocks have 5% - 10% up and down days regularly and overall down 30% - 50% from ATH. 

The pre-market can be deeply red and the day can end slightly green or close to it like today.  Market can reverse anytime in any direction like playing Uno reverse card. 

The world is still hella messy. Fear of second covid wave in Europe, Asia, and even America. Big government wants to spend trillions of dollars. More spending and more stimulus so the market should go up right? Wait a second, how about inflation? 

Same information, mixed understanding, and complete opposite decision on the market. So far, the sell side seems winning but the market seems to be really confused on where it should go.",ngg05f,[],1
7813,2021-05-19,wallstreetbets,"[5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

[5/18 Recap and 5/19 Outlook](https://www.reddit.com/r/wallstreetbets/comments/nfmpfq/i_spy_518_recap_and_519_outlook/?utm_source=share&utm_medium=web2x&context=3)

# 5/19 Recap 5/20 Outlook (Bold)

* Neutral
* Close @ 410.86
* High of 411.05 or .02 from a bullish price target listed this morning. 
* Hit ðŸŽ¯ 410 and 411.03
* **Bulls need to fill remainder of gap and close above 415 tomorrow. Look for a battle at 414-415 resistance and 417-418 resistance.**
* **Could see some fuckery around 412 also but it shouldn't be substantial IMO.** 
* **Bears need to hold 412.17 - 414 - 415**

https://preview.redd.it/oi3f01i2x4071.png?width=2163&format=png&auto=webp&s=e29733449606020b773915ca161677f5eec0168a

# W-Shape Thesis Note

* As stated as a possibility this morning it appears that we may be at the bottom and beginning to form the last line of our w-shape recovery. 
* **Need to close around 415 - 416 - 417**
* **If so, look to test ATH early next week IMO - pending any black swan event.** 
* **Gap fill 410.53 - 411.34**

https://preview.redd.it/wtipvagt15071.png?width=2468&format=png&auto=webp&s=eadc31caa2d462da755bc25289c2c6c1423ed8b4

[From 5/19 Morning Read](https://www.reddit.com/r/wallstreetbets/comments/ng51gn/i_spy_519_read/)

https://preview.redd.it/1a6jzadzw4071.png?width=368&format=png&auto=webp&s=6482414631fa618bd905af4c6f183a7b1d12fb58

https://preview.redd.it/b9qy3brdy4071.png?width=1025&format=png&auto=webp&s=9abadb666231264b62a013003c85a5d825d1e3d7

# 1 Day RSI under 50. 

* **Bears want to see it under 50 obv.**
* **Bulls want to see it over 50 obv.**

https://preview.redd.it/g46gz95o05071.png?width=2468&format=png&auto=webp&s=f17ce78247cfa522dfdacbd3e1d98b2b0df52e95

# SPY v VIX

* **Bears need 24+**
* **Bulls need 20-**

https://preview.redd.it/hahsfaoe25071.png?width=2163&format=png&auto=webp&s=dea683323058d002f72eedefda87b83f2c7cd022

Thanks for reading,

NightMan",ngglg9,[],0
7814,2021-05-19,wallstreetbets,"I thought I'd share a price action based technical analysis side due diligence. I believe a lot of investors don't necessarily look at this point of view because ""time in the markets, beats timing the market"" but hear me out. I do recall Benjamin Graham also didn't really understand this whole thing but I have reason to believe if I'm as ""shrewd"" of an enterprising investor as the man suggests, I should use every tool at my disposal in order for a better informed decision to be made. 




If I want a good suit and the offer on the tag is $1000. I can take it at market value, or choose to negotiate the price to end up with a good ~10%/20% discount. That's approx $200 saved just by talking. A save that you can get a good shirt, knickers and socks to go with your new suit. This is how I see price action technical analysis. Looking for the best possible price to pay for a share. Now to business.




#Apple Inc


Ticker **$AAPL** - has been ranging since last year between ~$100 and ~$140. This is promptly after we had the split from ~$330. You would imagine that some investors who weren't involved see this as an opportunity to buy more into the company at an affordable price per share, there are definitely also other investors looking to liquidate their holdings in order to get another ride out of the stock at a good price. 



The [distribution schematic chart](https://imgur.com/voCVxwf) and annotations for visual.
At **PSY** which we would call the preliminary supply, is where the first batch of selling took place, hence the ""pause"" in price at the level. But as you would have guessed, investors ""_bought the dip_"" which resulted in a strong price advance until it reached the buying climax (**BCLX**). 



At this point is where a lot of institutions unload more of their shares while buying is still high. Most uninformed investors will buy a share at any price given, this is why it's so easy for the big guys to distribute / liquidate his positions while we prop up the price.



With the first batch distributed, price will automatically drop back to support - this is the automatic reaction (**AR**). This is obviously because there aren't any *strong hands* fully committed to the stock anymore, at least at that point in time.




But since we keep buying the dip (not just novice investors, even professional fund managers may also get in the buying pressure), price will rally up again until the secondary test (**ST**). Again supply comes in the market as shares are being liquidated and price drops back to **support**. Now we have a trendline we can use to buy our stock as price keeps dipping. While doing this, it creates a low higher than the previous meaning - the stock is still trending upwards, giving investors hope that price found a floor and will continue pushing higher



This is why after the up thrust (**UT**), price drops just a little then pushes even higher. This would be the up thrust after distribution (**UTAD**). The big money here has now left the party. Their big sell orders are even seen at the supply volume (see bottom of the screen) This reminds me of the situation with Berkshire Hathaway saying it was a ""big mistake"" to sell their Apple holdings but here's something you should understand.



An investor cannot stay married to his investment for life. His aim is to get in at a good price, get out when his objective has been met, making a good profit out of the situation. Warren and his partners ""bought low and sold dear""  as they always advise, made a comment as if it was a mistake but really they probably want to buy again, but some profits have to be taken along the way and this is a great example. 



Once the shares have been distributed into the market, price keeps dropping. The trick here is to tire out other investors interested in making money in this market. This means, once we ""buy the dip"" off the support number 2 trendline we are given a bit of hope then after price keeps plummeting.



**Why I believe we're reaccumulating now**? 

Price is most likely going to break and close below the trendline support, [inducing fear](https://imgur.com/oCYJz0l) and forcing early buyers to sell out of their positions. There could even be bad fundamentals over the next few weeks/months on the company, or missed earnings. This contribute to price declines. 



While this may be seen as negative, institutional investors who know what they are doing get a lot of shares available to purchase at very discounted prices because sensational media has scared the individual investor out of his positions (*sometimes even fund managers who don't know what they're doing will sell out during bad news and declines*). 



This would be the process called a terminal shakeout, or a spring. This is when a lot of fear is in the market, shares being sold at a loss transferring the shares from weak hands (uninformed/novice investors) to strong hands. In situations like these, buying at the bottom of the range is best and price will eventually blow past the ""ceiling"" that's been keeping it low.



This level is where my [limit orders](https://imgur.com/mqm1yyv) are placed. 



Once price has strong commitment, big money will then eventually once again take control of the stock price and a mark-up would ensue. 




**This whole process can take weeks, or even months before it fully unfolds but it eventually does. The analysis here is based on _price behavioral systems_ developed by Richard D. Wyckoff, a technical analysis titan almost a century ago and retaught by the late Prof. Hank Pruden from San Francisco, Golden Gate University** With this, you can pair up with the typical fundamental DD mostly shared in these boards


I would enjoy a healthy commentary below. Best wishes



TL;DR. AAPL stock may induce fear causing early buyers to dump their stock into the hands of institutions in the next weeks/months. The best prices to buy in may be around $85-$100 and targets are set to record highs ($300+) based on the **law of cause and effect**. The range may be coming to an end. 


TL;DR 2. ðŸ¦ Stands on elevated ground and pees on an anthill. Eats two green (unripe) bananas and beats his chest a few times. Jumps on an ~~AAPL~~ apple tree and ðŸš€ðŸš€ emojis! From $100",nggpql,['AAPL'],0
7816,2021-05-19,wallstreetbets,"For those who invest in the steel industry, you will agree that Nucor (NUE) is the best-in class of al the steel makers. The company has excellent management, owns a considerable amount of share through multiple end-markets, and generates high free cash flow for a commodity producing firm. Its stock performance has shown its strength, with its stock price rising from $50 to over $100 in the past 3 months. 

Previously, I wrote about why US Steel (X) could provide 2X or 3X returns. Why I do not believe that NUE will hit $300 this year, I do believe that it is worth considering in your portfolio.  With the steel prices continuing to maintain at all time highs, Nucor has provided record results with that are expected to continue to grow this year.

**Nucorâ€™s advantage**

Unlike traditional steel makers that use blast furnaces to produce steel, NUE operates electric arc furnaces (EAFs) to produce steel. The EAF is different from the blast furnace as it produces steel by using an electrical current to melt scrap steel and/or direct reduced iron. The EAF uses scrap steel and electricity to produce molten steel. EAFs are generally cheaper to operate and allow NUE to adjust to changes in market demand. This advantage has allowed NUE to become the #1 steel producer in the United States and one of the most profitable in the world.

**Record breaking year**

Last month, Nucor posted a record quarterly profit of $942.4 million, or $3.10 per share for the first three months of 2021. [https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:\~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said](https://www.cnbc.com/2021/04/23/nucor-ceo-expects-strong-2021-after-posting-record-quarterly-profit.html#:~:text=The%20company%20recorded%20%247%20billion,mills%20segment%2C%20the%20company%20said). This was the most profitable quarter in the companyâ€™s history, and next quarter will be even better.

Going forward, analyst expect the company to earn approximately $12.89 per share. These high earnings are attributable to the rise in steel prices. Earlier this month, the price of hot rolled steel touched above $1,600/ton before pulling back. 

**$3 Billion share buyback**

After posting record numbers, NUE announced that its Board has approved the repurchase of up to $3 billion of the company's outstanding common stock. Companies generally use share buybacks as a way to return capital to investors when they believe their share price is too low. As of the time writing this post, NUE has a $30 billion market cap, which means this buyback program could effectively buy back 10% of the shares outstanding.

This new share repurchase program replaces the previously authorized $2 billion buyback program. The company sees repurchase of shares to be made in frequent time intervals in the open market at prevailing market prices, through private transactions or block trades. The amount and time of repurchase will rely on market conditions, share price, applicable legal requirements and other factors. The new repurchase authorization is discretionary and has no expiration date. [https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce\_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce\_referrer\_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ\_ieRDdSq0qf12RjsZSebw\_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy](https://finance.yahoo.com/news/nucors-nue-board-approves-upto-144402940.html?guccounter=1&guce_referrer=aHR0cHM6Ly93d3cuZ29vZ2xlLmNvbS8&guce_referrer_sig=AQAAACWBuv6e3QIgwJwbEyZcMzIm66vAqeGiL87eT9covILaILC4gFtHpmnTaiEHNE9OPGnnneWieYG1U74csNNaKjKXw4cBpfsBJ_ieRDdSq0qf12RjsZSebw_XIQZFZVEmDoE6zpM6XPkdt3ntlkWaDhbrNxIpzGe4hzzV8kcUowPy)

In addition to the buyback, the company has raised its dividend every year. With the recent run up in the stock price, the annual dividend of $1.62 only provides a 1.6% return. However, I would not be surprised if the dividend was raised again after their next earnings (July 21, 2021).

**The future is bright**

Recently, Nucor and Array Technologies, one of the world's largest manufacturers of ground-mounting systems used in solar energy projects, announced a supply agreement that aims to benefit both companies. Under the new agreement, NUE will supply the solar company with torque tubes and rolled steel, which are needed for Array's production of several parts and components used in its solar systems.

It should be noted that NUE already supplies various products to the solar industry. Last year, the company said orders for products in the renewable sector had already exceeded the 2019 volume by 15% just through September 2020.

**Other considerations**

As a tailwind for the steel industry, President Biden has proposed a major infrastructure plan, which not only includes major spending on roads, bridges, pipelines, which will help all steel producers, but the plan also contains various spending plans on renewable projects, which could also go to help NUEâ€™s growth. 

It is expected that this will bill will pass, even it cannot get Republican support. The infrastructure plan will cause billions in spending on steel products, which could keep steel prices higher for longer than currently anticipated.

**Conclusion**

NUE is a great company and a great long-term play. Itâ€™s stock has had a good run over the past few months, and investors should look to any dips as an opportunity to enter. For investors with more of a risk appetite, companies like X or CLF could offer greater returns.",nghmhm,[],0
7818,2021-05-19,wallstreetbets,"Long time lurker, seldom poster.

Petco earnings is tomorrow pre-market. But this also might be a potential candidate for a short squeeze.

Short sellers are gearing up for a bad quarter. For the last three days, the short float increased from 4 point-something Monday, 6.05 yesterday, and today it's at 8.75.

In addition, short interest is up to 35.2%

To top it off, there are hardly any shares available to short, though borrowing rate remains at only 1%. For the last five days there were no more than 100k shares left to short.

The average price target is $28, but if earnings goes better than expected, this could be the catalyst for something significantly bigger. Listen to your pets' beckoning calls, and keep this on your watch list!

&#x200B;

[https://shortablestocks.com/](https://shortablestocks.com/)

[https://iborrowdesk.com/report/WOOF](https://iborrowdesk.com/report/WOOF)

[https://finviz.com/quote.ashx?t=WOOF](https://finviz.com/quote.ashx?t=WOOF)",ngj411,[],0
7820,2021-05-19,wallstreetbets,"After an epic beatdown from a short seller report, $RIDE appears to have risen from the dead and is once again poised to reward investors.

The stock is up 64% since the close on 5/13, through 5/19. Closing volume has ramped up steadily over the same period from 6.3m to 42.4m

Two major catalysts are on the near horizon:

1) Earnings report on 5/24 AH: Confirmation of late Q3 production and disclosure of binding orders have a high probability of being announced.

2) Lordstown Week (June 21-25): Plant open house for tours, test drives, etc., and above all else, transparency.  This should alone should put the final nail in the shorts coffin.

It's still not too late to jump on the $RIDE train and ***squeeze*** the life out of the naysayers. All aboard!

[5D \/ 10M](https://preview.redd.it/7bfqp7c0u5071.jpg?width=1596&format=pjpg&auto=webp&s=ec7a2da79406490d6f960a124b39bedd2a5d5474)

&#x200B;

[Price \/ Volume](https://preview.redd.it/zuhw6jb5u5071.jpg?width=982&format=pjpg&auto=webp&s=c923d65279aa2d6579cfe5851c630978da9cdbc2)

&#x200B;

[Positions](https://preview.redd.it/4e73gslau5071.jpg?width=1124&format=pjpg&auto=webp&s=83072316f8f334da5df34b97f4b8fd20b569969c)",ngkfy8,[],1
7821,2021-05-19,wallstreetbets,"WTI sold off over the past week, dragging down energy stocks. Iâ€™ve been interested in $TPL but missed the big run up. Is this an opportunity to buy the dip? 

The view/catalysts would be:
- spiking oil from summer demand
- oil super cycle
- annual shareholder meeting in November (first meeting as a C-Corp with huge voting power in the hands of the Horizon Kinetics following: expect big changes?)

Any long time followers out there? Is valuation too stretched for you?",ngkucz,[],0
7823,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
7825,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
7827,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
7828,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
7831,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
7832,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
7833,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
7839,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
7840,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
7841,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
7844,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
7848,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
7850,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
7851,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
7854,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
7857,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
7858,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
7859,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
7860,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
7863,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
7865,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
7869,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
7876,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
7877,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
7879,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
7880,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
7883,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
7889,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
7898,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
7899,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
7901,2021-05-21,wallstreetbets,"This happened roughly 4 hours ago from making this post and the new terms go into effect June 1st. 

I really think this is huge for GOOG/GOOGL ad revenue. According to socialblade, there are 56 million channels under 1k subs(10-999) as of November 13 2020. Youtube previously demonetized smaller channels but I guess is going all in.

From Youtube: ""YouTubeâ€™s right to monetize: YouTube has the right to monetize all content on the platform and ads may appear on videos from channels not in the YouTubeÂ PartnerÂ Program.""

With GOOG's stock rising $600 EPS over the past 6 months and with this, I almost see nothing that can stop tremendous ad revenue and a moderate EPS during Q3 earnings call.",nhj72c,[],0
7903,2021-05-21,wallstreetbets,"If you're still kicking yourself about not putting your entire 401k into Shopify and getting those sweet 40x gains, I think BIGC may be one of the next hot stocks.

Currently BIGC is trading at 17x revenue and I think that a fair value for this stock is 20 to 40x revenue (especially since it will be compared with Shopify). Average growth the past few years per quarter is around 8.4% per quarter.

Currently the stock is down this year trading around $50, peak was $140 last year.

Projecting out growth over 5 years shows that:

1. 2021: Revenue $211M, stock $60 to $120
2. 2022: Revenue $292M, stock $83 to $166
3. 2023: Revenue $403M, stock $114 to $230
4. 2024: Revenue $556M, stock $158 to $316
5. 2025: Revenue $768M, stock $218 to $437
6. 2026: Revenue $1B, stock $302 to $604

Personally I think that as the company continues to show strong growth the share price will grow overvalued in the short term (before EOY). I do think the stock will be a 5 to 10x bagger in the next five years though. They may also be able to hit $1B in revenue sooner than 2026.

TLDR; BIGC good, like SHOP, but undervalued.

Position: 2000 shares @ $55

>!(research is my own and might be garbage. never take advice from strangers)!<",nhjghj,[],1
8478,2021-05-20,wallstreetbets,"Huge Put option play on AMC over the next week.  Last time there was a bull run on the stock got to the same resistance (3/11-3/18) up 42.1% to $14.54 then on 3/19 slight drop of (0.5%) that was followed up by a (10.3%) drop on 3/22 and further drops of (14.7%) on 3/23 and (15.4%) on 3/24.  

Weâ€™ve had a run up of 55% from 5/6-5/17 to $14.38 high on 5/17.  Slight gain of 0.6% on 5/18 (similar to the slight drop on 3/19 with freaky similar volume changes) and then the massive sell off decline on 5/19 of (9.9%) is eerily similar to the (10.3%) drop on 3/22.......

Potential to give up all of the gains since 5/6 by this Friday and puts are ridiculously cheap in the $10 below range for 5/21 and 5/28.  If AMC goes on a similar slide to the March slide, there will be massive returns on these ridiculously cheap put options (9.9% decline today and the sub $10 puts barely moved in price on both the 5/21 and 5/28 expiration dates.

Cheap way to place a bet if the squeeze doesnâ€™t materialize that could be a >10x return based on how cheap the <$10 puts are for 5/21 and 5/28 put options.

If you are holding stock, max gains you are getting for $20 is ~2x but this could be the real money maker with puts sub $10 priced at $0.01-$0.05 that could go to $0.5+ if the stock slides similar to the March slide.  If the squeeze materializes then you make all your money there and lose alittle on some cheap put options that could be the real money makers.",ngnwaq,['AMC'],0
8480,2021-05-20,wallstreetbets,"Can RIDE keep going like wtf?? The announcement of Lordstown Week is proving to be serious catalyst. 

This Lordstown Week idea shows supreme confidence in their own legitimacy and ought to erase many doubts stemming from the short report and SEC investigation. This inspired a ton of buying pressure and bull flag after bull flag. 

There are 2 more catalysts on the horizon:

1. Earnings - Monday 5/24: could always be a rug pull... or the next leg up. Fisker moved upward after their earnings, as investors got excited by the Foxconn partnership amongst other things and understood their too young of a company to have substantial figures. RIDE's coming earnings gives them to speak on some hard numbers. ""Soft,"" speculative numbers are what they've been investigated for previously so this will shed some light, as well as any speak on any progress and projects they are working on. 
2. Lordstown Week - June 21-25: This is a full week event at their plant in Ohio. The guts of the operations will be open to the media and investors alike. the first 3 days will have media coverage. The event will include factory tours, presentations and test drives of the Endurance.

&#x200B;

I've been waiting for a red day since I heard the news after the pop, but idk if there will be one between now and Monday. And Monday could be an explosion or implosion. I don't have any positions, but I am thinking of buying shares and Fall calls. I just wanted to get some genuine discussion on a hot stock that is surely striking fomo in many of us",ngoehj,[],0
8482,2021-05-20,wallstreetbets,"Who art in federal prison, hollowed be thy gainz, thy greens run long, thy reds be none, with stocks, as it is with options.

Give us today our daily DDs, and forgive us our FDS, as we forgive those who inverse against us.

And lead us not into margin calls, but deliver us our tendies.

For bags full of jNUG, ayyMD, and RAD. Now until earnings. Amen


* For those of you that don't know Dr. Martin Shkreli, he was what you would call a true degenerate. At one point he was the most hated person in the entire country.

Shkreli has bought the Wu Tang Clan song that has never been released, for 3 million dollars, just because he can.

He drove up the price of a medicine he owned more than 5400%, just because he could.

He was investigated by the SEC and Congress for securities fraud.

He bought stupid shit just because he can.

He hosted hours of streams of YouTube videos on how to analyze biotech stocks,

He found a hedge fund wich he blew up, and had to pay the investors back with stocks from his biotech company.

For the newbies here, he was our lord and savior before this sub blew up like Japan when it got bombed the fuck out of it.

He was more of a degenerate then, DFV. He was a true wsb retard. He is currently serving 7 years of and has 2 more years. When he gets out, get ready. This whole sub will turn upside down. LITERALLY. until next time, YOLO, just YOLO!",ngptnw,[],0
8483,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
8486,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
8487,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
8488,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
8494,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
8495,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
8496,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
8499,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
8503,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
8505,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
8506,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
8509,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
8512,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
8513,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
8514,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
8515,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
8518,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
8520,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
8524,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
8531,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
8532,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
8534,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
8535,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
8538,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
8544,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
8553,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
8554,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
8556,2021-05-21,wallstreetbets,"This happened roughly 4 hours ago from making this post and the new terms go into effect June 1st. 

I really think this is huge for GOOG/GOOGL ad revenue. According to socialblade, there are 56 million channels under 1k subs(10-999) as of November 13 2020. Youtube previously demonetized smaller channels but I guess is going all in.

From Youtube: ""YouTubeâ€™s right to monetize: YouTube has the right to monetize all content on the platform and ads may appear on videos from channels not in the YouTubeÂ PartnerÂ Program.""

With GOOG's stock rising $600 EPS over the past 6 months and with this, I almost see nothing that can stop tremendous ad revenue and a moderate EPS during Q3 earnings call.",nhj72c,[],0
8558,2021-05-21,wallstreetbets,"If you're still kicking yourself about not putting your entire 401k into Shopify and getting those sweet 40x gains, I think BIGC may be one of the next hot stocks.

Currently BIGC is trading at 17x revenue and I think that a fair value for this stock is 20 to 40x revenue (especially since it will be compared with Shopify). Average growth the past few years per quarter is around 8.4% per quarter.

Currently the stock is down this year trading around $50, peak was $140 last year.

Projecting out growth over 5 years shows that:

1. 2021: Revenue $211M, stock $60 to $120
2. 2022: Revenue $292M, stock $83 to $166
3. 2023: Revenue $403M, stock $114 to $230
4. 2024: Revenue $556M, stock $158 to $316
5. 2025: Revenue $768M, stock $218 to $437
6. 2026: Revenue $1B, stock $302 to $604

Personally I think that as the company continues to show strong growth the share price will grow overvalued in the short term (before EOY). I do think the stock will be a 5 to 10x bagger in the next five years though. They may also be able to hit $1B in revenue sooner than 2026.

TLDR; BIGC good, like SHOP, but undervalued.

Position: 2000 shares @ $55

>!(research is my own and might be garbage. never take advice from strangers)!<",nhjghj,[],1
8565,2021-05-21,wallstreetbets,"This is a web based business, yet they make it impossible to send them an ACH. Even after the account is verified, there appears to be no way to actually send them money. It's as if they hate cash, and want it to stay far away from them.

The help documents have no instructions as to how to actually accomplish this.

Furthermore their support contact is broken, after several attempts I gave up. There is also no phone contact which can reach an actual human. 

The coinbase reddit page autoblocked my post there. The only other support option is twitter, there is no way in hell I'm doing that.

TLDR; broken website, no support",nhjzjh,[],0
9146,2021-05-20,wallstreetbets,"Some context: Cell carriers in the US have decided to stop the function of shared short codes (5-6 digit phone numbers) June 1. Shared short codes were the preferred means of SMS and MMS communication for B2C traffic. Short codes were free to lease in many cases, text messages were cheap, thousands of businesses could send from the same number, and throughput was incredibly high (lots of messages could be sent very fast).

The new policy enforced by the CTIA (The private club all major cell phone carriers are in) is that shared short codes are to be discontinued and replaced by dedicated short codes and A2P 10dlc (approved B2C traffic on 10-digit phone numbers). This means that every business/organization that wants to send texts must either apply for a dedicated short code or apply for a 10DLC. 

Dedicated short codes are the preferred choice for large corporations. They can handle large throughput and look good for the brand. However, they only cater to large corporations because they are thousands of dollars/year to lease. Turn around time for application is 4-6 weeks. Barrier to entry is high.

10DLC is the preferred choice for the smaller businesses since it's less expensive. But, it is still far more expensive than the shared short codes businesses are used to, requires application, and costs $50/mo in carrier and registration fees alone. Turn around time for application is less than a week. On top of fees, 10dlc isn't even fully ready. The Campaign Registry, the organization responsible for rolling out ""the new messaging standard"" for the CTIA, is still developing their API.

Enter Toll-free messaging. TF has 0 barrier to entry and can be issued to a business with SMS and MMS capabilities in seconds. It's the easiest and now the most cost-effective way to send commercial messages.

Conveniently, every major carrier announced this month (for the first time) that they will start collecting a $0.0025/message fee for every sms sent. They're ready for and expecting businesses to move to this method.

Who is Zipwhip: Zipwhip was given full reign over all TF traffic. Anyone in the US  that wants to send messages on TF codes uses Zipwhip in one way or another. They are a massive reseller that everyone is required to go through.

It was recently announced the Twilio plans on acquiring Zipwhip for $850M. Twilio is the leader is programmable messaging hands down. 

Honestly, there should be antitrust issues that arise and block the acquisition. If it goes through, Twilio owns the new world of business sms. Good chance regulators won't notice any issue. They'll miss the fact that businesses will be pressured into TF over their preferred solutions (dedicated short codes and A2P 10DLC) since it's unnecessarily complicated and expensive. TF is ready now and cheap.

TL;DR if Twilio successfully acquires Zipwhip, every small to medium sized business that wants to send texts will have to go through them. Every single one of them in the US.",ngrqqf,[],0
9149,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
9150,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
9151,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
9157,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
9158,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
9159,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
9162,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
9166,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
9168,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
9169,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
9172,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
9175,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
9176,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
9177,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
9178,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
9181,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
9183,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
9187,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
9194,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
9195,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
9197,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
9198,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
9201,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
9207,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
9216,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
9217,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
9219,2021-05-21,wallstreetbets,"This happened roughly 4 hours ago from making this post and the new terms go into effect June 1st. 

I really think this is huge for GOOG/GOOGL ad revenue. According to socialblade, there are 56 million channels under 1k subs(10-999) as of November 13 2020. Youtube previously demonetized smaller channels but I guess is going all in.

From Youtube: ""YouTubeâ€™s right to monetize: YouTube has the right to monetize all content on the platform and ads may appear on videos from channels not in the YouTubeÂ PartnerÂ Program.""

With GOOG's stock rising $600 EPS over the past 6 months and with this, I almost see nothing that can stop tremendous ad revenue and a moderate EPS during Q3 earnings call.",nhj72c,[],0
9221,2021-05-21,wallstreetbets,"If you're still kicking yourself about not putting your entire 401k into Shopify and getting those sweet 40x gains, I think BIGC may be one of the next hot stocks.

Currently BIGC is trading at 17x revenue and I think that a fair value for this stock is 20 to 40x revenue (especially since it will be compared with Shopify). Average growth the past few years per quarter is around 8.4% per quarter.

Currently the stock is down this year trading around $50, peak was $140 last year.

Projecting out growth over 5 years shows that:

1. 2021: Revenue $211M, stock $60 to $120
2. 2022: Revenue $292M, stock $83 to $166
3. 2023: Revenue $403M, stock $114 to $230
4. 2024: Revenue $556M, stock $158 to $316
5. 2025: Revenue $768M, stock $218 to $437
6. 2026: Revenue $1B, stock $302 to $604

Personally I think that as the company continues to show strong growth the share price will grow overvalued in the short term (before EOY). I do think the stock will be a 5 to 10x bagger in the next five years though. They may also be able to hit $1B in revenue sooner than 2026.

TLDR; BIGC good, like SHOP, but undervalued.

Position: 2000 shares @ $55

>!(research is my own and might be garbage. never take advice from strangers)!<",nhjghj,[],1
9228,2021-05-21,wallstreetbets,"This is a web based business, yet they make it impossible to send them an ACH. Even after the account is verified, there appears to be no way to actually send them money. It's as if they hate cash, and want it to stay far away from them.

The help documents have no instructions as to how to actually accomplish this.

Furthermore their support contact is broken, after several attempts I gave up. There is also no phone contact which can reach an actual human. 

The coinbase reddit page autoblocked my post there. The only other support option is twitter, there is no way in hell I'm doing that.

TLDR; broken website, no support",nhjzjh,[],0
9534,2021-05-20,wallstreetbets,"So, I am ready to make a long term investment and I had this idea:

SpaceX will revolutionize how Humans interact with Space over the next 10-30 years. If this statement stands true, what companies other than SpaceX (because it is not publicly tradeable) will benefit heavily from this fact?

Rocket suppliers/material suppliers/someone in the supply chain etc. What does SpaceX need that someone else will provide (and is already positioned to do so) that could benefit heavily from SpaceX expanding it's business?

Any thoughts?",nguxep,[],0
9535,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB |^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)


[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",ngw4ld,[],1
9541,2021-05-20,wallstreetbets,"[5/19 Recap and 5/20 Outlook](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

# SPY - Neutral

**SPY SPOT GAMMA:**

Gamma Index: Decreased to -0.18 ( look for rapid directional changes.)		

Vol Trigger: Unchanged		

Abs Gamma Strike: Decreased to 400 (may function as a â€œmagnetâ€ and large liquidity area.)		

Gamma Notional: Decreased to -804 (implies higher volatility in the underlying.)		

Put Wall Support: Decreased to 405 (bullish indication.)		

Call Wall Strike: Unchanged		

Gamma Tilt: Decreased to 0.79	 (bearish indication)	

Net Delta: Decreased to 208,045 (decrease in net long hedge but still near highs)		

25d risk reversal: Unchanged		

Topp Abs Gamma Strikes: 	\[415, 410, 405, 400\]

https://preview.redd.it/jcsrhwx1t9071.png?width=2144&format=png&auto=webp&s=1d93f3e75107c8fe906cf0a0f40490f9eb8cb986

**TA Notes: 15 min timeframe**

* Support at 20 SMMA
* Resistance at 60, 120 SMMA, and gap fill
* If 412 is filled - look at 414-415 resistance ðŸŽ¯
* If resistance breaks - look for ðŸ‚ ðŸŽ¯ 416.81 - 417.55 - 419 - 420 - 420.53 ( I see us possibly topping at 416-417 if we can break resistance.)
* Look for support at 410-408
* Look for ðŸ» ðŸŽ¯ at  406.48 - 405 - 404.68 - 403.36 - 400.54 - 400
* We have strong support at 400. 

https://preview.redd.it/a76cvdigw9071.png?width=2786&format=png&auto=webp&s=c5e02cc2a15457f02e79f8fcdeebcc2c8925aa1f

Thanks for reading and Godspeed Friends!

NightMan",ngzlre,[],0
9542,2021-05-20,wallstreetbets,"$UWMC Due Diligence - Don't knock it til you read it, or don't I'm a reddit post not a cop.

By now most of us are familiar with UWMC and its +23% run in the past week. A stock with a massive dividend. A stock trading with a very low P/E of and income growth of 4,200%.

So why is this stock still a buy and hold for me right now?

The CEO is positioning them to increase shareholder value, but also position the company to weather any reduction in the refi market. (65% of the business)

There are major catalysts that have been driving the increase in price that goes beyond the attention gained on WSB.

* Announced **NET earnings of $860M in the first quarter,** with huge margins.
* Reaffirmed a continued dividend, the next ex-dividend date is **6/9/2021**.
* Announced a **$300M stock buyback, representing as much as 40% of the free float** at the current prices.
* Russell index inclusion was missed last quarter due to confusion about their PREVIOUS status as a SPAC. It is expected that they will be reconsidered for Russell Index inclusions in the yearly reconstitution. While not the biggest catalyst, this is a sign of reputation and long-term stability for the stock. **The prelim list publishes 6/4/2021.**
* Creation of a jumbo mortgage product. The average loan origination in the market is \~410,000, indicating that the non-conforming section of the mortgage market is *exploding.* This is a very profitable sector of loan origination.

Other fundamentals driving a buy recommendation:

* Small float. 90M float, of which only about 60M is freely trading.
* This stock is not persistently pressured down quite as hard as others due to low share availability, but it appears based on the last two weeks it's trading the small waves of this stock to try to push it down under dangerous strike prices. A wave of positive sentiment could strangle this position in the stock. I don't have a Bloomberg terminal, but based on the evidence over the last several days, the indication is the 13.1% SI has grown.
* Exceptional open option interest for **tomorrow 5/21/2021.** The options expiring tomorrow have been documented elsewhere so I won't belabor them, but the open interest at the $9, and $10 strike represent almost 10% of the free float.
* Not a new startup, **they have been in this business since 1986**, making them almost as old as a fossil like me. They clearly survived the 2008 storm. This company isn't going anywhere anytime soon.

The cherry:

* **STILL forecasting growth in Q2**, whereas many of its competitors are not.

This post is NOT financial advice, but as someone who has ridden the waves of this stock since it was about $9, I see this position turning positive and the outlook through July for this position has high sentiment. Even if the mortgage market slows down as expected, I will hold these shares for years to come for the dividends and general stability of the organization.

My position 8000 shares @ 7.65 and 45x 6/18 8c. You can go stalk the fuck out of me if you want to see that I've been talking about this stock for some time and been saying the same thing about the strength and targets of their position since March. I am also the guy that tells you when you unintentionally reveal personal info on your yolo screenshots!

TLDR: UWMC should garner close attention for value investors looking for undervalued positions.

can't stop the work.

EDIT: Proof of positions, and time invested. [https://imgur.com/a/4NRXSpH](https://imgur.com/a/4NRXSpH)

&#x200B;",ngzq1l,[],0
9543,2021-05-20,wallstreetbets,"**Investment Thesis**

Overall, what makes MDXG a good buying opportunity right now is a combination of two factors.

* Number one is managementâ€™s miscommunication with the market. The market currently believes that wound care is the core business of MDXG, is not entirely aware of the potential of its biopharma pipeline and more specifically its Amniofix drug, and has priced the company based on this.Â 
* Number two is the huge potential of the Amniofix treatment and its ability to become the next blockbuster in the healthcare space after the conclusion of its phase 3 trial.

**Idea Summary**

MiMedx Group *(MDXG)* is a leading BioPharma and wound care business whose value has been drastically misunderstood by the market. Through drivers such as miscommunication from management about the companyâ€™s valued proposition as well as the lack of institutional investor coverage, the market currently believes that the majority of the companyâ€™s value sits in its low growth wound care business. In reality, its major competitive advantage is within its osteoarthritis drug Amniofix which has the potential to become the next blockbuster after it clears phase III clinical trials. A sum of the parts valuation was used to determine a minimum implied upside of at least 300%. Risks are discussed at the end.

**Business Overview**

MiMedx Group is a leading biopharma and advanced wound care business utilizing human placental tissues to develop products used in the healthcare sector. It processes placental tissues using its patented processes to produce allografts, which are tissues transplanted from one person to another for wound care and regeneration. These allografts are effective in healing difficult wounds because of the ability of the allograft cells to quickly associate with the cells of the patient, thereby taking part in the healing process, easing the ability of the body to close the wound, and speeding up the bodyâ€™s regeneration process.

MDXGâ€™s product offerings can be split into two business segments: wound care and biopharma (surgical solutions). Its flagship product Epifix and additional product Epicord fall under its wound care umbrella, and its flagship product Amniofix as well as additional products Amniocord, Amniofill, and Epiburn fall under its biopharma umbrella. The wound care products service the broad wound care industry, targeting specifically chronic wounds. The biopharma product line is more specific, with the flagship treatment Amniofix targeting knee osteoarthritis in specific.Â 

MDXG sells through direct sales, sales agents, and distributors in the United States. This past quarter, 95% of its sales were direct to customers such as healthcare professionals and facilities.Â 

**Internal Analysis**

The past 3 years have not been ideal for MDXG. Its revenues began to dip in 2018 around the time of their accounting scandal, the growth went from 40% in 2018, to 11% in 2019, and is currently around -16%. This sent their stock price tumbling from $16 USD to lows of almost $1 USD, though it is currently trading at $9 with new updates on their biopharma pipeline.

Their gross margin has stayed very high, around 80% while their EBITDA margins have dropped over the years. Though it wasnâ€™t explicitly disclosed, a large part of this drop in EBITDA margins has been attributed to a temporary increase in legal fees due to the litigation MDXG has faced this past year. Its decreased volume may have also suppressed margins as the number of wound care treatments in hospitals significantly dropped during COVID-19.Â 

The companyâ€™s cash balance is sitting at a very high level of 84 mm. This is in large part due to its recent capital raise, which happened to be strongly criticized by one of MDXGâ€™s activist investors, Prescience Point Capital (discussed in detail later).

**External Analysis**

*Wound Care Market*

The global wound care market is expected to grow at a CAGR of 4.1% from 2021 to 2028. This has been driven by the aging population and rising rates of chronic diseases such as diabetes and cancer. Wound care products are increasingly being used to prevent and surgical site infections.Â 

Though the overall market is projected to grow at a CAGR of 4.1% the specific advanced product segment which includes products such as those of MDXGâ€™s which target chronic and non-healing wounds, is projected to grow much faster than 4.1%.Â 

The wound care market is relatively fragmented, with large players such as Integra LifeSciences, 3M, Johnson & Johnson, and Medtronic competing to gain the most market share. MDXGâ€™s direct competition for its allograft advanced wound care treatments include Organogenesis, Axogen, Mediwound, and Vericel.Â 

Organogenesis is currently in the lead in this niche market, and while MDXG reported an 11% YoY decline in sales in 2020 (which has already been factored into the current price), Organogenesis reported a 30% increase. This is evident when comparing the stock performance of both companies over the past year (figure 1)

*Osteoarthritis Therapy Market*

91 million U.S. adults have arthritis, 20M have knee OA, and \~32 million per year are currently treated for plantar fasciitis, which is specifically targeted by MDXGâ€™s Amniofix drug. There are very few FDA approved treatments for knee OA and plantar fasciitis, and those that exist have low efficacy and many drawbacks. Amniofix is currently the only treatment of its nature in phase 3 clinical trials that have posted very positive results in both company and independent trials, has been used off-label by >100K patients with zero severe adverse effects, and consistently demonstrates a significant reduction in pain as reported by patients. In addition, Amniofix has an RMAT (regenerative medicine advanced therapy) designation granted by the FDA which allows for MDXG to benefit from an expedited approval process from the FDA.

*Management Miscommunication*

The current market opinion of MDXG has been blurred by the miscommunication from company management whose goals do not align with maximizing shareholder value. This is largely due to the fact that EW healthcare, a private equity firm, has 33% representation on the board as a result of its 17% stake. From a corporate finance perspective, a private equity firmâ€™s interests do not generally tend to align with those of public shareholders. Their influence has been exacerbated by the fact that there are no large institutional holdings in MDXG as of yet other than Prescience Point, and there has been minimal coverage on the stock leading to the marketâ€™s opinion on the company being heavily skewed by management communications.Â 

MDXGâ€™s current growth strategy is focused on roll-ups in the wound care space. This is very characteristic of a private equity playbook, and goes alongside EWâ€™s historical acquisitions. As was mentioned in the external analysis, the wound care space is growing at a slow rate of \~4.1%, however MDXG has lost significant market share to Organogenesis. Management has failed to realize that the current value driver of the business is within its biopharma line and not its wound care line, yet has continually communicated to shareholders that it believes it is in fact wound care and it is going to continue investing in growing within the industry.

Prescience Point Capital, an activist investor group which has advocated for change in MDXG's communication strategy, has supported the fact that MDXGâ€™s communications have been focused on the wrong industry. At the JP Morgan Healthcare Conference, the potential for the drug Amniofix was drastically undersold and much time was spent convincing investors that the core business is in wound care. The 3.6% decline in shares two days after the conference illustrates how effective this strategy was.Â 

There has been strong opposition from MDXGâ€™s board of directors to Prescience Pointâ€™s activist efforts. In a shareholder letter in early May, prior to their annual meeting, the company communicated that they believe the wound care and regenerative medicine direction being followed now is ideal. They stated that the activist investor does not understand pharmaceutical company disclosure and were advocating for speculative actions themselves though Prescienceâ€™s report discusses the opposite, with them outlining how EWâ€™s influence on the board of directors is shifting the companyâ€™s focus away from maximizing shareholder value.

*Amniofix*

As mentioned in the external analysis, there is currently no other treatment, either in development or on the market, as effective as Amniofix in treating knee OA and also just as safe. Most recently, at its Q1 earnings call, MDXG CEO shared positive results from the phase IIb prospective trial of the treatment. There was a statistically significant reduction in VAS (visual analog score) for pain and an improvement in the foot function index score. There were also no serious adverse events during this clinical trial. Amniofix is currently in phase III trials, and MDXG believes they are on target to meet all criteria needed to find a biologics license application (BLA) so that the treatment can be introduced to the general public. MDXG is aiming to file their BLA in the first half of 2022, meaning that within a year this blockbuster treatment could be on the market, and given the feedback so far from clinical trials as well as the RMAT designation, it is highly likely.

A Prescience Point market capture analysis estimated that the treatment would bring in $4,050 million of annual sales. This is \~8 times higher than the current sales brought in through wound care. One year ago it would have been prudent to not entirely incorporate this into the share price, however today with clinical trials nearing completion and MDXGâ€™s new RMAT designation, the likelihood of approval is much higher.

**Valuation**

From a valuation point of view, a quick sum of the parts analysis is the most ideal given the two different business lines of MDXG. A more in-depth DCF can be created once more cost information is provided from MDXG after the conclusion of clinical trials.

Shares outstanding of 109.8 mm, total debt of 51.8 mm, and total cash of 84.7mm were used to convert from enterprise value to equity value. The current implied upside was calculated using the current price of $9.46.

*Wound Care Valuation*

MDXGâ€™s FY 2021 sales guidance assumed $255 mm to $270 mm in revenue from the wound care segment. Different points in this revenue ranged were used for the low, base, and high cases of the valuation. An EV/Revenue multiple was used to calculate implied enterprise value. The comparables analysis shown in figure 2 illustrated the median multiples derived from the analysis done using the aforementioned list of MDXGâ€™s competitors. A median multiple of 5.3x was used. The median was used and not marked down because the gross margin and UFCF yield of MDXG is in-line with all competitors. Though the EBIDTA multiple was lower, the similar yield and gross margins indicate that company performance is relatively the same. In addition, litigation expenses factored into the lower EBIDTA multiples and thus it is not indicative of recurring performance.

Based on the revenue multiples, implied share values for the wound care segment range between $12.0 and $12.8.

**Wound Care Equity Value**

https://preview.redd.it/dibh93jl1a071.png?width=549&format=png&auto=webp&s=2c1871e08591796daa0a434274332cd9a4353258

**Biopharma Valuation**

Prescience Point estimated annual revenues from Amniofix through using the market capture method. The total market size (annual knee OA injections) was estimated, and a capture percentage was applied to determine the annual number of patients receiving the Amniofix injection. Prescience assumed 1.5 injections per year but to be more conservative in this valuation 1 was used. Price per injection and FDA approval probability varied by the cases and were used to adjust the EV/Rev multiple downwards. Overall, an implied share value range between $25.4 and $57.1 was calculated for this segment.

https://preview.redd.it/we0pw4jm1a071.png?width=611&format=png&auto=webp&s=567d19cc5acc59acbe552a2afcf09789c80866ff

**Biopharma Equity Value**

Overall, the total implied share price ranges between $37.43 to $69.81. As more information regarding Amniofix comes out including the price of manufacturing, different multiples can be used to fine-tune the analysis.

https://preview.redd.it/a8035yfo1a071.png?width=517&format=png&auto=webp&s=12e0f9a041e326b505bfda25304261367c651406

**Risks**

1. Given the high influence EW healthcare has on the board of directors, there is potential for more value to describe acquisitions such as that of stability biologics, which was bought for 10 million and sold for 3.5 million 3 years later. If such a trend continues, the value of MDXGâ€™s wound care business can dramatically decrease, which will hurt the share pierce
2. The FDA approval of Amniofix is a large driver of the valuation calculated. There is a large risk that the FDA will not approve the treatment, however, with the RMAT designation in place and positive results from the first two phases of clinical trials, the odds are strongly in the favour of the approval at the current point in time.

Overall MDXG has been strongly misrepresented by management leading to a skewed opinion and pricing by the market.",nh08j4,[],0
9546,2021-05-20,wallstreetbets,"This all hinges on on a hunch that SPCE is announcing the test flight in an attempt to cancel it in order to buy more time. Their previous test flight crashed so they should be extra careful during the next one, however SPCE picked the most dangerous day in terms of weather for their flight.

&#x200B;

&#x200B;

Look at the weather for spaceport America. The only day with clouds and precipitation is Saturday. The day they chose. They just announced the test flight today so they must have known about the weather ahead of time.

&#x200B;

https://preview.redd.it/qfvc1jru5a071.jpg?width=1375&format=pjpg&auto=webp&s=3a7960aeb612d069ad7e92bbd02ed0034cc7ff00

In addition to the chance of rain, there is also the wind:

&#x200B;

&#x200B;

https://preview.redd.it/2alivlfg6a071.jpg?width=1537&format=pjpg&auto=webp&s=ee01ab03f0a61f5f9709e0e3bbd9e59661737ffa

Saturday has the most wind of any day.

&#x200B;

&#x200B;

Why would they choose this saturday, the only day in the past 2 weeks that is cloudy with a chance of rain. Look at the weather history for that area:

&#x200B;

[https://www.timeanddate.com/weather/usa/las-cruces/historic](https://www.timeanddate.com/weather/usa/las-cruces/historic)

&#x200B;

Saturday will have the worst weather in the past 2 months and they decided to pick that day of all days. Every other day is sunshine and calm winds except the day they chose.

&#x200B;

Do with this information as you will.

&#x200B;

28 May 18 Puts for me

&#x200B;

EDIT:

&#x200B;

You guys realized they have had weather cancellations because of rain before right?",nh12y5,['SPCE'],1
9550,2021-05-20,wallstreetbets,"So - this is another setup I've been watching closely for quite a long time. I've got two different charts I want to talk about today. For those who don't know, $EEM - or the iShares Emerging Markets ETF - is comprised of stocks from developing nations, with a **ton** of room to grow. These countries **will** all catch up soon, it's only a matter of time. This is one of the many reasons I find this setup especially interesting.

Here are the top holdings:

[$EEM Holdings \(By Country\)](https://preview.redd.it/zh7nwb2hfa071.png?width=755&format=png&auto=webp&s=90cb2749a2c7d6c7f548ad89a3f9a746b56d2273)

Next, let's dig into the charts -

Chart 1: **Max Monthly (\~16 Years)**

[$EEM Max Monthly](https://preview.redd.it/ylknrqzhea071.png?width=2246&format=png&auto=webp&s=91ee9718b89c47744e6f68224a133c48c7bcfc6f)

Here you can see we have a **symmetrical triangle** pattern that dates back to late 2007. In technical analysis, the longer the pattern has been building, the more significant the breakout will be. Subsequently - you can imagine the magnitude a pattern like this has.

When making new all time highs I like to look for psychological resistances. As a result - logical targets for this pattern are **75.00, 100.00.** Sounds simple, but it works in practice. Keep in mind - something like this will take **3 - 5 years** to play out. This is a position trade.

In order for this breakout to stay valid - we need to continue getting monthly closes above **50.85.** You can see we've pretty much gone perfectly sideways since breaking out for **4 months** now.

This is **bullish -** moving sideways in a higher range is always biased to the upside (except in special situations with certain reversal patterns). Not only that, but we've been forming an interesting setup on the next chart I will show you all -

Chart 2: **1 Year 1 Day**

[$EEM 1 Year 1 Day](https://preview.redd.it/7hy7wbqeea071.png?width=2246&format=png&auto=webp&s=8102c5b1f0e92c02260cfccc6b8d77eafea8035d)

On this chart - you can make much more sense of those 4 months of sideways. We are actually working on a large **falling wedge** \- which is a bullish continuation pattern. The breakout point for this is sitting around **54.37** as I am writing this (5/20/2021).

Upon breaking this (ignoring the previous chart) - we would target **54.94, 56.49, 57.32, 60.00, 65.00.** That would be if there was no setup on the monthly chart. Each of these are resistances we could stop and consolidate at. I like to scale in after breaking each resistance. Scale into winners and cut losers fast. A break from a pattern like this would probably take **3 - 6 months** to play out.

I also want to note that **MASSIVE** increase in volume on 3/26. Generally - an uptick on volume when price is doing what you want it to is always a plus. But one like that is very intriguing - on a huge green candle too. My guess would be someone loaded their bags there (or a group of players).

And... **that's it.** Keep it simple. Those are often the best setups.

***TL;DR -***

$EEM has a big pattern - broke out 4 months ago just chopping sideways waiting for the move to happen.

Price targets **75.00, 100.00**

Stop out below **50.87** monthly close

Timeframe **3-5 years**

It also has a smaller pattern above that one - which breaks out above **54.37** and has a shorter time horizon.

Price targets **60.00, 65.00**

Stop out if we close back inside

Timeframe **3-6 months**

***Positions -***

10% of my long term portfolio is in emerging markets ETFs and,

August **55c @ 0.91** \- Will always roll these back before they get below 60 DTE - Will scale in heavily after the smaller pattern breaks out

*Not Financial Advice*",nh2zrs,[],0
9552,2021-05-20,wallstreetbets,"Mind Medicine is currently undervalued as a biotech company...

\- Research coming out of John Hopkins University is suggesting that the use of Psilocybin is the most effective drug ever tested as a remedy for depression, anxiety, and PTSD. As the United States is currently under crisis in its battle against mental illness, these results are too impressive to ignore, even if it may need to overcome pressures from big pharma interest groups that seek to quell the expansion of this research.

\- These drugs have been extremely effective in treating addiction -- particularly alcohol and nicotine. Considering the government expenditure on the opioid crisis, once this proves to be an effective treatment, the government will expedite the medicinal legalization of the substances that MNMD has been treating/experimenting with.

\- Veterans, the most respected occupational category (statistically,) have begun launching advocacy groups for the widespread medicinal legalization of these substances due to their effectiveness against PTSD. These therapeutic measures have contributed to the plummeting of suicide rates (those treated w/ psilocybin vs. control group.) The Biden administration will have to choose ethics and reason over the suffering of veterans (former government employees) which I anticipate that they will given mounting pressure due to the effectiveness of these treatments.

&#x200B;

Does this hinge on expected earnings in the long-run ... certainly!

&#x200B;

But the effectiveness of this research is undeniable and can no longer be overlooked ... because of new cultural acceptance of these alternative treatments the government's hand will be forced in legalize, or otherwise be responsible for mental illness and addiction -- all of which could be treated and cured.

&#x200B;

Please take this a Macro, long-term prediction given trends in biotech and mental illness research.",nh3khq,[],1
9553,2021-05-20,wallstreetbets,"I want to first start off by saying that I'm not liable for financial losses. I recently built an app that can generate efficient frontiers when you plug in individual US Equities. 

If you aren't familiar with the efficient frontier, what it tries to find is the *mean-variance portfolio.* This type of model deals with portfolio management / optimization. In terms of the efficient frontier you are trying to find the best portfolio allocation weights that give you the best risk adjusted returns. 

**In simple words:** you give it stocks and it tells you the best percentage holdings

I recently built an app on some python code that does this sort of optimization. There is no programming required to use the app. When running the app it will give two portfolios, minimum variance, and maximized sharpe (same as mean-variance, mean-markowitz). Minimum variance will tell you the least riskiest holding strategy (green), and max sharpe will give you the best reward-for-risk holding (red). I call that portfolio *the-juice-is-worth-the-squeeze.* Here is a sample output. 

&#x200B;

https://preview.redd.it/z7nc04xura071.png?width=803&format=png&auto=webp&s=861ffb8d4eaabb382d64208d6c21f99aae3506aa

I used around 100,000 simulations, and 10Y of adjusted close data. 

The reason why I bring this up is because it does two things. The first is that it promotes portfolio diversification, which I know is pretty uncommon here. Also it finds the most aggressive returns in terms of minimizing risk. If you have high returns and wonder why you returns are so much higher than standard investment funds its probably because you are here

https://preview.redd.it/qrmgyru6ta071.png?width=596&format=png&auto=webp&s=b8f856e00960d9d8669f442edf7729e2ddbfaae5

Yah you may good returns, you are probably taking on more risk than what you are getting in return.

&#x200B;

**If your brain has folds in it:**

Essentially the code is using a monte carlo simulation to solve this optimization problem. 

https://preview.redd.it/cayj7k5ita071.png?width=703&format=png&auto=webp&s=899ef3dc8c245ec1da6ca1163f4b6223934128c8

link to app: [here](https://share.streamlit.io/diegodalvarez/streamlit_efficient_frontier/efficient_frontier_streamlit_base.py)

link to codebase: [here](https://github.com/diegodalvarez/streamlit_efficient_frontier)",nh45af,[],0
9556,2021-05-20,wallstreetbets,"Alright, listen up fuck heads. Today Virgin galactic just released this Tweet. They're planning to test out their new space ship 22nd May, and if the test flight is successful, then SPCE go to da moon.   ðŸš€  ðŸš€ 

https://preview.redd.it/atjw6r0lza071.png?width=604&format=png&auto=webp&s=5dee70e4fcf252de71da4829d35816b716396bd4

  
How high could it go? Well If we take a look at the graph below, we can see that SPCE peaked at around 60 bucks  back in February in ANTICIPATION for the previous test flight which was delayed until May for safety reasons (They had some problems with electromagnetic interference which is fixed now). 

https://preview.redd.it/7gkt6q2b0b071.png?width=709&format=png&auto=webp&s=cf751660b6ec987adb3614000e9d1d19f4dd6b7b

So if the test flight actually happens on the 22nd, then could be really big boom. Currently the price is around 18-19 bucks, so it's an absolute steal in my opinion, but there is always the risk that some shit fucks up and the test flight is delayed even further, in which case I will have to sell the house.

And before any of you autistic fucks say that SpaceX is better, just keep in mind that Virgin Galactic is playing a whole different game. SpaceX is trying to go to Mars, and Virgin Galactic is just trying to do some space tourism. Also keep in mind that Virgin Galactic was founded 2 whole years after SpaceX, so SpaceX has had a bit of a head start.

To conclude, possibly spaceship go fly this weekend, if so, big money, if no, I go bankrupt.",nh5b5z,['SPCE'],0
9559,2021-05-20,wallstreetbets,"I have done so much DD on this play and I really want to share it with you guys since WSB is the reason I started investing over a year ago.

In this post I'm going to not talk about some kind of currency that can get this post removed. Hint: it crashed big time yesterday. You know the one.

There is a new kind of this currency that uses a lot of computer storage space. How much? Well - 7 EXABYTES and it's currently adding 1 exabyte every 3 days. I'm going to assume you know about this currency and if not you can look through my post history and see which subreddit I've posted to recently involving this particular one.

#Topics of discussion:

* Why WDC is going to moon in the next 2-12 weeks

* WDC Fundamentals

* Bear case

#If you are reading this on May 20th - you are early

WDC just came off one of their best earnings beats in recent memory. WDC was a beaten-down stock in 2018 after NAND (SSD memory) prices declined, and analysts thought that HDDs (spinning disk hard drives) were going the way of the dinosaur. WDC did see a big increase in data center sales and consumer devices (think external drives for work from home setups) during Covid, but analysts priced in declining sales in 2021 as covid restrictions begin to end. By all accounts, it looked like WDC had no future growth prospects and should be some kind of dividend-yielding boomer stock. WDC reported earnings in April for the quarter ended March 31 - with revenues down only 1% compared to the 20% that analysts expected. The EPS was way higher than expected - non-gaap was expected to be around 0.68, and WDC delivered 1.02. The analysts are already wrong and they don't know what else is coming: The new currency thing that I won't name. They didn't even mention it in the earnings call. None of the investors on the line in the Q&A even asked about it. It's totally under the radar. In the next quarter, WDC is going to deliver their biggest earnings beat ever, and they are going to raise their revenue guidance for the rest of the year as a result, possibly by a gigantic, unheard of margin due to the new demand caused by the currency. When this happens, this stock is going to test its ATHs at around $110 per share but I would not be surprised to see a new ATH far above anything in the past. This stock can double, and it's going to happen AT THE LATEST during WDC's next earnings call. This is expected first week of August. 

#Fundamentals

WDC is an American company, they have been publicly traded since 1973 and they have been part of the S&P 500 index since 2009. This is a solid company - we are not betting on dog shit turning to gold, we are betting on gold turning to diamond. WDC has like 64k employees, and is vertically integrated in HDDs and SDDs thanks to a long road of acquisitions like SanDisk in 2016. They own their own supply chain, so they can make bigger margins in the event of the inevitable price increases reminiscent of the GPU market thanks to another currency.

WDC is close to fairly valued at the moment at about $70 per share. They saw some spikes to 75+ recently after earnings but it keeps selling off due to WDC suspending their dividend and boomers wanting out, plus S&P indexes falling and selling off here and there. Suspending the dividend is MAJOR good news. This company has been stagnant for a while, but they are ready to expand. They want to be a growth company again, and they are going to get it when they realize increased HDD and SSD demand is here to stay.

#The new reality is not priced in: WDC's TAM market just increased 50% and nobody knows about it

An industry expert at Forbes, Tom Coughlin, has estimated that WDC shipped 125 exabytes of HDD storage for Q1 2021. Next quarter, they are expected to ship around the same amount. WDC says there is seasonality but I really don't see it in the numbers. WDC owns somewhere about 35-40% of the HDD market, and around 17% of the SSD market.

The new currency is currently at 7 exabytes and consumes around 300+ petabytes daily at this point. Even after yesterday's events, the profitability is so high that even if it loses 50% of it's value, it's still worth buying HDDs over MSRP. Farmers can buy HDDs at $50 per TB (double the msrp market rate before the rise) and break even in 1 month. This is unheard of in the space. That's how profitable this is. While it's hard to farm solo if you are a small time farmer, it's worth it for the whales and the whales will eat HDDs until a 8TB drive goes for $400. WDC and Seagate are selling every drive they they can possibly make. If we apply WDC's market share to the current size of the network, we are looking at, conservatively, 2.5 exabytes of extra sales that is not expected or accounted for. 

Let's look at it another way - with 125 exabytes shipped in Q1, 90 days, that means WDC ships 1.38 exabytes daily. Half of this goes to datacenter clients in long-term contracts, so say 700 petabytes daily. If the new currency is growing at 300 petabytes daily, and 40% of those drives are WDC, that's an extra 17% more demand than anyone so far knows about. If that doesn't seem like a lot, it's because it's massively understated and not nearly as high as it is in reality.

The network space is a lagging indicator. People buy hard drives ahead of time, and fill them with plots over time. Plotting speed is the bottleneck. Behind that 7 exabytes of networks space is likely 7 exabytes empty space already purchased, waiting to be consumed, or even more. And its not only farmers buying drives - scalpers are buying drives to scalp the farmers too. Go look on amazon and tell me how many drives you see in stock that are bigger than 6 TB. They are sold out. Supply is also a bottleneck - the new currency would grow even faster if they could buy even more storage. For all intents and purposes, that 700 petabytes of storage provided to consumers daily is almost all consumed by currency farmers. If they could deliver double the storage to consumers, at 1.4 exabytes per day, they would probably still sell all of them.

But wait - there's more.

WDC also makes SSDs, and Seagate does not (Seagate has 0.2% marketshare of SSDs). I didn't think the new currency would have much affect on the SSD market since the are needed in far smaller quantities than HDDs, and the go-to has mostly been enterprise drives by Intel and Samsung rather than WDC. But I was wrong. Just this morning, I was making my rounds on Amazon and noticed that WD SN750s 1TBs are almost out of stock, there are only 2 available. SN750 2TBs are out of stock. SN 850s are sold out. I'll go into why this is significant.

A company called Phison makes SSD controllers. They recently said they are raising their prices 10% due to supply constraints as the new currency has driven up SSD demand. This is a big indicator that the SSD demand is actually super high. You know those SN drives I talked about earlier almost being out of stock? Yeah, WDC makes their own controllers for those. They don't need Phison. If other manufacturers have to buy more expensive controllers, WDC can just raise their prices and make that profit themselves. SSD demand is certainly less than HDD and it's lagging behind HDD, but an NVME SSD drive shortage could be right around the corner. The new currency is very intensive on the SSDs and they are destroyed quickly, so buying NVMEs are not one-time purchases, they are like the gas the fuels the car. They will need to be purchased as more and more HDDs are purchased continually.

#Bear case

Nobody likes bears so I will address the risks quickly. The obvious risk is that the new currency is over priced and will either die out completely or crash to the point people will stop buying HDDs and the demand will only be a momentary spike in the rear view. I strongly do not believe this is the case and I think yesterday is a good test that shows that even under extreme pressure, the new currency is well positioned and strong. It's not going to 0 because of a market crash. I can go far into detail into why I believe this new currency is here to stay, and the demand will persist for potentially years, but I would have to say enough words that I think this post will just be removed.

The second risk is that NAND flash memory continues to decline in price. Since the pandemic the price has gone up, as datacenters are forced to expand, but I think the effects of the pandemic are not going to end any time soon and in fact that there will be no return to normal at all. I believe work from home is just going to be part of the future regardless of covid, which means more network and more servers and more data is going to be needed. I think the analyst expectation that revenue would collapse in 2021 as the pandemic ends and being surprised that it at least remained flat is going to be wind in WDC's sails even apart from the new currency's affects.

The third risk is management not dealing with the new currency demand well. If they are really bearish on the currency, they may not raise supply enough to capitalize on the increased demand. They may think the demand is temporary and they will be left with oversupply if they ramp now. David Goeckeler became CEO of WDC last year and he's got a background in tech of course, but more specifically in Cisco. He is known for transformational leadership and I think that shows with his decision to suspend the WDC dividend. If he is looking to transform WDC, I think this is the perfect opportunity for him. 

#Summary TL;DR

HDD demand has sold out everything there is to sell out. Price increases are imminent, and SSDs could follow soon. All of this is due to a new currency that uses HDDs and SSDs, which is currently so profitable that whales will continue to buy them even at 30, 50 or 100% premiums. None of this was accounted for in WDC's most recent earnings call, and the price has not reacted to it yet. This thing is a ticking time bomb. WDC was already on track to a better than expected 2021 and this will launch it to interstellar space.

ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€PositionsðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€ðŸš€

[157 shares (Canadians unite!)](https://i.imgur.com/6y4p3ax.jpg)

[1 leap Jan '23 70c](https://i.imgur.com/SAqvMhA.jpg)

I believe that this trend is lasting all year and we are going to $150+. If you want to make a short term play and go balls deep I recommend July or October calls for 80-90c. If WDC's next earnings are the catalyst, the July calls may not be the best value, but there is a pretty good chance that the market will wake up and see that WDC is killing it well before the first week of August. If you are a real smooth brain ape, you can't go wrong with shares. There is virtually no downside risk, WDC was already turning heads this year even without the new currency. STONKS ONLY GO UP",nh5tbi,[],1
9560,2021-05-20,wallstreetbets,"**Bionano Genomics (BNGO)** has had the recent momentum with earnings, fundamentals are improving, and the research and technology are **consistently making advancements.** Although it is still considered a speculative growth stock, I believe it is trending in the right in all facets. 

\*\*\*My average in @ $5.10, currently at $5.52, May 20th, 2021

I am not investing in the company as a get-rich-quick scheme, but plan to hold long term. **Saphyr** technology will continue to improve directly with design improvements, but also indirectly with the data that it continuously collects will create more accurate correlations of DNA with individual predispositions for disease. 

I believe the technology will allow for a more personal approach in the field of medicine, and should not be viewed solely as a research-based company.  

Recent earnings showed it was being stunted by large laboratory facilities having covid restrictions. The future increase in revenue will be reflected by the number of consumables the company sells. These consumables are required for every iteration the Saphyr Machine conducts. More machine sales lead to more consumables used, and in turn, will create the ability for cheaper future consumable production and ultimately greater and more feasible adoption of technology throughout the scientific and medical community. 

* **Large institutional investments have nearly tripled (3X) from 5% to 14%.** 
* **Earnings beat expectations in Q1 2021.**
* **Recent large insider procurement.**
* **New patents, research breakthroughs, Large Lab facility adoption.**

This is why I have a strong conviction for **Bionano Genomics (BNGO)** being a great growth stock to investigate and follow. 

There are some negative indicators fundamentally, but considering Bionano is still in its infancy I am very optimistic in my outlook. The positives tip the scale in my opinion and at the very least, Bianano Genomics (BNGO) should be on your watchlist!

**I look forward to the comments and welcome skeptical viewpoints. Open to hearing what other perceptions and expectations are of this company, Thanks for reading!!!!**

^(\*\*I am currently in the field of Aerospace Engineering in R&D, so I am not an expert on Biological studies, although I double majored in Bio-medical engineering. Practical knowledge of tech is based on my wife's experiences, she is a medical provider and utilizes genomic studies in Oncology to suggest and find the most effective methods for specific people with particular cancers.)",nh6256,[],1
9561,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/xgzs5cf68b071.png?width=2612&format=png&auto=webp&s=d8535ad6ea1db47e9a4d1f79a424a235ce286800",nh66wz,['AAPL'],0
9562,2021-05-20,wallstreetbets,"Looking closely at how the next couple of days go in AAPL. If we see a reversal back to the down side there could be a large pullback since this would confirm a daily head and shoulders break to the down side. Looking for a measured move from head the neckline, which falls the in the range of also filling a gap @ $96.19.

https://preview.redd.it/5vud70vi9b071.png?width=2612&format=png&auto=webp&s=2683dbb1bd8257c82ad5a0133e2f5b01e0feeaa4

Also, this past week AAPL has been testing it's 200 day moving average. If we continue the rally strong from this area then it will invalidate the head and shoulders pattern outlined above. If we close below that (currently @ $123.69) that would give more confirmation of this head and shoulders break to the downside.

Another point of interest is that the SlowRSI is currently @ 33.29. Typically a bottom is put in when this reaches the 20 level or below. This itself is no reason for a pullback, but everything said put together strengthens the pullback argument.

All said and done, I am bullish on AAPL but believe we need to see a deep pullback in order for it to be more attractive to the masses and drive more volume into the stock. After this potential pullback I can see AAPL rallying hard to the upside, so pay attention and be patient for a good entry.",nh6ijq,['AAPL'],0
9565,2021-05-20,wallstreetbets," 

A little bit about myself for context:

1. I work in enterprise mergers and acquisitions.
2. I've been an armature securities analyst for about 6-7 years now.
3. I'm careful about where I put my money. Pubmatic is a compelling investment, so lets get into it.

What is Pubmatic?

* Pubmatic was founded in 2006 and operates in programmatic digital advertising market. They are generally considered an old school adtech company by much of the adtech community. In a nutshell, their platform-as-a-service provides tools to help connect publishers to advertisers so that they can sell ads. Pubmatic is known as an ""SSP"" or supply-side-platform. Supply being ad inventory on a publisher's website. Advertisers looking to purchase ad inventory will work with their own demand-side-platform or ""DSP"" and the whole transaction happens automatically. This has advantages over simply calling up a publisher and purchasing the ads in person. Namely speed and data analytics that these platforms have. Keep in mind that I am no expert in adtech whatsoever. Here is a high level info graphic:

&#x200B;

https://preview.redd.it/555339dhob071.png?width=1920&format=png&auto=webp&s=42585b1cfe4cf1c85eab62b0cc01791f5321f1e2

* I would encourage you to look into this further, as it is quite interesting and fun to learn about.

The SSP Market:

* Unlike the DSP side of the equation, the SSP market is highly saturated and commoditized. I've found dozens and dozens of SSP competitors and they generally sell the same ad inventory. Publishers often times will work with many different SSPs to sell their inventory in an effort to capture as much revenue as possible. This has led to the saturation of the market and you see publishers sometimes working with 10-20 SSPs at a time. So how does an SSP compete?

The competition:

* There are a few different ways SSPs can compete with one another. Technology and scale are the two that come to mind. If an SSP has sophisticated analytics or advanced features, it's an easier sell to publishers. Additionally, if an SSP can operate at a large scale, they can get a higher percentage of the ad dollars flowing to the publishers, and can provide better fees. Pubmatic is the 3rd largest SSP behind Google and Magnite\* (**fact check needed**).
* The biggest players in this market are Google, Facebook, and Amazon. These are obviously some heavy hitters and they control a majority of the internet. They are often called ""walled gardens."" Think about youtube ads for example. Google simply sells their own youtube ads using their own adtech installations, no need for Pubmatic. They can also buy ads from themselves and put Google ads on youtube. So they play both sides of the market. It is extraordinarily difficult to compete with them since they are basically the government of the internet and control a mind-blowing amount of personal data on each and every one of us. However, the ""open internet"" is still very much alive and growing, and this is where Pubmatic competes.

History lesson section: I'll need to do some more research on the history of the programmatic ad market and I'll post it in the next DD. Historical context is important to the story. Basically though, the digital advertising market is constantly going through dramatic shifts. If you look back, Pubmatic has grown resilient based on the fact that they've needed to reinvent their products a few times over. Some examples are the rise of header bidding, and most recently the sunset of the 3rd party cookie in Chrome. This is why Pubmatic doesn't hold any debt. Their revenue stream is sensitive to market shifts.

Pubmatic's Moat:

1. I don't have much insight into the competitive advantages of Pubmatic over other SSPs, but I can definitely say that there is some kind of moat.  

   1. First:  

      1. Pubmatic's net dollar based retention rate is 130%, up from 121% last year. That tells me that for one reason or another, more ad dollars are flowing through their platform. This is probably due to the SPO deals that they've been cutting, or ""supply path optimization."" These deals cut out a number of the existing SSPs that a publisher works with, and drives up market share for Pubmatic. They've been making these deals for a while now and it's a big growth driver. Smaller SSPs are going to suffer, but Pubmatic is big and a beneficiary of this phenomenon.
   2. Second:  

      1. Management describes their competitive advantage as being an ""infrastructure first"" company. This is unique - they own their own infrastructure rather than operating on something like AWS. I'll get into their financials later, but I like this part of their business. Magnite and many other SSPs operate on AWS, so they're giving a portion of their revenue to Amazon, who also competes with them. So you can see how that's a problem. Also, by owning their own infrastructure, Pubmatic can engineer their way to better outcomes for the publishers and advertisers. They are still working on this, but theoretically, they could offer lower prices and faster speeds. They aren't there yet, however. Take a look at their cost per ad impression:

&#x200B;

https://preview.redd.it/kffnxp4gob071.png?width=961&format=png&auto=webp&s=db940e67eaabd3471afac9b2d50c7765744964ed

A nice downtrend on the costs. This is the benefit of the infrastructure first approach.

And yes, the T on the left is TRILLION. They deliver trillions and trillions of ad impressions every month.

1. One final note on the moat: creating a moat in the SSP market is notoriously difficult, but somehow Pubmatic seems to have found one. I would love to hear more from someone experienced in this space to help me understand better. A lot of the adtech community describes Pubmatic as ""generic"" or ""not interesting,"" but the numbers tell a much different story. Lets get into that next.

Pubmatic product and revenue mix - This will be in the next post.

1. High level:  

   1. Mostly mobile ad sales
   2. omnichannel - meaning they can sell inventory across multiple channels (desktop, CTV, mobile, etc)
   3. One note about CTV  

      1. Linear TV (boomer style cable television) is going by the way side in favor of connected tv, or CTV. CTV is compelling because there are no walled gardens controlling the market, so it is all up for grabs. Competition is quickly heating up between the likes of Disney, Roku, Fubo, Magnite (through Spotx M&A), and others. Pubmatic has a CTV implementation, but they were late to the party. That said, they already have the necessary tech to compete in CTV, so now it's just a matter of selling it. They'll need to work harder though to steal market share from competitors.

Financial condition:

1. This is the part that gets *very* interesting. Pubmatic's financial condition is really something special:  

   1. 18.5% GAAP net profit margin for 2020
   2. 32% EBITDA margin
   3. Zero debt
   4. 73% Gross profit margin
   5. 7+ years of positive free cash flow

These type of numbers clearly say that there is something here. Nothing about these numbers is ""generic."" If Magnite's products are so much better and if Magnite is a ""market leader"", why are they losing market share and not growing organically? Why are their margins worse even though they have a larger scale? Why haven't they been able to achieve high profitability? Seems to me that Pubmatic isn't so ""generic"" after all. But again, **I am not an expert in adtech**, so please please fill me in if you know more.

Revenue and margins have been increasing nicely over the last 3 years, even with the COVID headwinds. Management has indicated a long term revenue growth rate of 20%. I'll make another post later with a more detailed financial analysis and valuation (hint: it's higher than 1.6 billion).

I want to stress how unusual it is for a growth stock IPO to have such a high level of profitability. Often times with IPOs, the company has to go out and prove that they can make it, or that they can grow into profitability. Pubmatic is already in a more mature state and path the higher risk phase of posting losses (Magnite is still 1-2 years away from profitability, that makes it more speculative)

""The next Trade Desk"" - I've heard this before. Bottom line: the SSP and DSP markets are different. There is no ""next trade desk"" The trade desk is leading the charge against the walled gardens, and no SSP will take that place simply because they aren't right in front of the advertisers. Advertisers pay for the internet, not publishers. That said, Pubmatic has high profit margins and growth rates, very similar to TTD.

Short interest:

1. Most people seem to be the most interested in this part, which is understandable. I find the above more compelling myself, but lets get into it :)  

   1. Public float:  

      1. \~7 million shares
      2. Yes you heard that right, just 7 million shares are available for purchase. It's not a mistake.
   2. Institutional ownership  

      1. North of 90%
      2. This is what makes the public float so small
   3. Short percentage  

      1. North of 50%
      2. This is not a mistake, it really is that high
      3. What's more, it seems like there is **just one fund shorting this stock**. Northern Lights Trust Fund II (**fact check needed**, I looked into their SEC filings, but I couldn't find where the short sales were shown)
   4. Speculation time:  

      1. **Tin foil hat activated**: Magnite is the primary competitor to Pubmatic. By almost every measure, Pubmatic is a better company. Wouldn't it make sense to coordinate with a fund to drive down the price of Pubmatic? If they didn't short to such a high degree, my guess is that Pubmatic would have an equal or higher market cap than Magnite even with less revenue. That would be very embarrassing for Magnite, so they need Pubmatic's price to struggle. And why not? With such a low float and low volume, it wouldn't be hard for a short seller to be in control of the price. I have half a mind to message management and find out what they plan to do about this. Why would a short seller short Pubmatic to such an intense degree? How could a smaller company (pubmatic) with better profitability, better margins, and better organic growth rates trade at a LOWER multiple than Magnite? Is SpotX really that good? What if the Disney contract falls through? Magnite is a good company, but I see red flags all over. Doesn't make much sense. **Tin foil hat deactivated**

Risks:

1. The adtech industry is constantly shifting and management will need to be nimble enough to roll with the changes or some other company is going to eat their lunch.  

   1. Rebuttal:  

      1. Pubmatic operates with a high level of efficiency and doesn't hold any debt. Their engineering team in India is crazy efficient. I have worked with similar teams in the past.
      2. Again, Pubmatic has been growing their revenue and profit margins for a long time. I think they understand that it is important to maintain a certain level of nimbleness.
2. The oligopolistic internet super powers (I.e. Google) figure out a way to crush them  

   1. Rebuttal  

      1. This is a risk, but they haven't been successful in crushing Pubmatic so far. In order to do this, these walled gardens would need to own the whole advertising market on the internet. This is a very low risk. The open internet isn't going anywhere.
3. Ad dollars drying up  

   1. Pubmatic is totally and completely at the mercy of advertisers spending money on their platform. If they stopped spending due to some unforeseen issue (global economic meltdown), they lose reveune  

      1. Rebuttal:
      2. We saw a huge drop off in ad dollars in Q2 2020 during the initial stages of the pandemic. Nevertheless, Pubmatic grew their revenue, so they've shown they can still compete even with this type of headwind.
4. Transparency  

   1. This is a weak point for Pubmatic. Transparency is becoming a hot ticket item. Advertisers are becoming more and more sensitive to where their ads get placed. For example: a family theme park isn't going to want their ads displayed on a porn site because it can damage their brand. They also want to defend against ad fraud, or when a bot clicks on an ad but obviously doesn't buy anything. Why would an advertiser want to pay good money for an ad if a bot is going to click it?  

      1. Rebuttal:
      2. Pubmatic needs to work on this. They have a fraud program that is available on all of their products, where they provide a refund if fraud is detected. So that is good, but I think they can do more. Pubmatic is incentivized to sell as many ads as possible, even to bots. I'm not sure what else they could do, but I think this could be a good selling point. I know that they've been giving more visibility into the data to publishers and advertisers, so that is good. Again, I think they could do more on this. That said, they aren't having any trouble selling their products, so maybe this isn't too big of an issue. At the very least, management mentions it all the time so they are aware of the concerns from advertisers.

That's it for now. **Please feel free to poke holes in the DD so far**. I consider DD to never be complete and I try to have a scientists perspective, where my conclusions are adjusted with new evidence. I have more to post, so please bear with me as I am very busy.",nh8f2j,[],0
9567,2021-05-20,wallstreetbets," So this is the first time I've ever played around with options and I'm probably doing it in a dumb way but get that's more fun for you guys to watch. I have 200 shares in BNGO with an average price of about $6 and I decided to sell 2 calls for $358 premium with a strike price of $12 expiring in January, 2023. Now I believe in BNGO and I think it could go to the moon. But I might have to stay on earth while I watch the rocket fly. My goal is to grow a dividend portfolio to pay me some good dividends while I'm a full time student and don't work a job currently. So here's what my current play is:

I sold those 2 calls for the $358 premium. If those calls get exercised I am perfectly fine with cashing out $2,400, which is roughly a $1,100 net profit off my original investment of $1,300. That $2,400 will very much go towards buying some great monthly dividend stocks. But I also decided to make another play to make things interesting.

I also decided to sell 1 put for a premium of $38 with a strike price of $5 expiring on June 18 of this year. I think BNGO can stay above that but even if it doesn't, I'm more than happy to buy 100 more shares. If I get assigned, I'll only have to pay $104, which I'm fine with.

So in summary, I could have a short term gain of $396 if the put expires worthless or a net loss of only $104 if BNGO closes under $5 on June 18. But even if I get assigned, I could always sell another $12 January 2023 covered call for those 100 for roughly \~$160, meaning I could still end up making a small profit when all is said and done. I have no idea if there's a name for this ""strategy"", if you can even call it that, or if I'm just a moron lol.

https://preview.redd.it/pno0yu47qb071.jpg?width=720&format=pjpg&auto=webp&s=e1d517b6e96693277b279bd3f2b415c68de0d354

https://preview.redd.it/pmm3lai8qb071.jpg?width=720&format=pjpg&auto=webp&s=a5e5fa638cd4cb977d5b349236c069eee557ff24",nh8q8x,[],1
9571,2021-05-20,wallstreetbets,"Your daily trading discussion thread. Please keep the shitposting to a minimum. 

^Navigate ^WSB|^We ^recommend ^best ^daily ^DD
:--|:--                                 
**DD** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADD) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADD&restrict_sr=on&t=week)
**Discussion** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ADiscussion) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ADiscussion&restrict_sr=on&t=week)
**YOLO** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AYOLO) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AYOLO&restrict_sr=on&t=week)
**Gain** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3AGain) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3AGain&restrict_sr=on&t=week)
**Loss** | [All](https://reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3ALoss) / [**Best Daily**](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=day) / [Best Weekly](https://www.reddit.com/r/wallstreetbets/search?sort=top&q=flair%3ALoss&restrict_sr=on&t=week)

[Weekly Earnings Discussion Thread](https://www.reddit.com/r/wallstreetbets/search?sort=new&restrict_sr=on&q=flair%3A%22Earnings%20Thread%22)

**Read the [rules](https://www.reddit.com/r/wallstreetbets/wiki/contentguide) and make sure other people follow them.**

Try [No Meme Mode](https://www.reddit.com/r/wallstreetbets/search/?q=-flair%3AMeme%20-flair%3ASatire%20-flair%3AShitpost&restrict_sr=1&t=day&sort=hot), also accessible through the top bar.

Follow [@Official_WSB](https://twitter.com/Official_WSB) on Twitter, all other accounts are impersonators.",nh9y3g,[],1
9578,2021-05-20,wallstreetbets,"The cruise line industry has been nearly brought to extinction during the pandemic, but with the vaccines being distributed, cruise lines are making a major comeback. 
This type of play has been a gamble based on whether cruise lines are coming back this year. Now, that uncertainty is disappearing. Carnival has announced that they will resume cruising this July!
Letâ€™s go over some pros and cons though.

Pros: 
1. They will resume cruising this year. The CDC has been loosening restrictions with cyclical industries except for cruise lines. But with pressures on the CDC, they finally gave in.

2. Carnival survived through the pandemic even with no revenue coming in. Having no revenue should be enough to destroy a business right? Well not for Carnival, they survived and in fact their assets increased throughout 2020. Their assets increased by 18% on their balance sheet from November 2019 - November 2020.

3. It has been announced that fully vaccinated people donâ€™t need to wear masks. This news just brings in more confidence that everything will soon be back to normal and that also means cruise lines will be back in action.

Cons:
1. COVID can mutate into something much worse. With the new mutation in India, thereâ€™s a possibility that in can spread across other countries. If that happens, cruising might be delayed even more and have to survive in their remaining cash.

2. Young Children are currently not allowed on cruises at the moment. Young Children are not able to take the COVID vaccines which are a requirement to board cruises. Families love going on cruises, but they will not be able to bring their little ones. So most likely Carnival would have to rely on the revenue coming from older folks/couples with upcoming anniversaries.

Overall, Iâ€™m bullish and have over 30 call contracts expiring this July ðŸš€ðŸš€ðŸš€",nhdnzi,[],0
9579,2021-05-20,wallstreetbets,"Everyone has shit on RKT over the past couple of weeks since forward guidance was down, but is choking on UWMCâ€™s cock, despite the fact that industry and market headwinds will affect both equally. There is little difference in their lines of business at the moment, margins are similar, products are similar. Thereâ€™s very little differentiation, heâ€™ll theyâ€™re in the same city. UWMC has had a better post-earnings period not because their top line YOY growth was so good or even indicative of something remotely possible to sustain moving forward, but really just because of the dividend and chest pounding against RKT.

I have a position in both, and before either camp starts screaming about how one is more revolutionary, or has better blah blah blah, realize that the only thing driving price action for either is public sentiment. UWMC declared a regular dividend while RKT only a special. 

Next week, either Jay Farner gets flashy (new dividend, massive auto rollout, something new) and starts publicly pushing back against Ishbia, or RKT continues downward. I think itâ€™s 50/50 but looks ripe for anyone looking for a straddle yolo, with IV not as bad as it was before.

Positions:
1000 x RKT
2000 x UWMC",nhdvbv,[],0
9581,2021-05-20,wallstreetbets,"Why does JPM have to save COMEX at all?  
It might be to their advantage to do so because they are able to profit off of the availability of COMEX -- but at what price?  
In other words, saving COMEX yet again may be becoming just too *expensive* for JPM's bean counters/risk managers.  
Or maybe they simply don't have the available unencumbered silver to do this with any longer.  
JPM and their billion ounce mountain of silver may be a paper tiger. 

&#x200B;

Lets dign in !

**Comex silver warehouse .... another 1,000,000 oz is OUT OF THE VAULT, 43,000,000 oz is gone since the silverbacks arrived. This time it is all HSBC bank. And what did big powerful JP Morgan do? Nothing!! Maybe all their silver eligible is spoken for.** 

 You may be wondering why I  track JP Morgan so closely. The short story is that registered stocks are very low compared to deliveries ... a Ratio of about 3 months of supply at current delivery rates.

Yeah, so what's that got to do with JP Morgan? In the past, like July 2020, JP Morgan rode in on their big black horse and deposited 30 million oz at the onset of July 2020 deliveries. This time, at the onset of May 2021 deliveries, they rode in on their little pony and deposited just 3 million oz.

Comex needs 50 million oz to get back to a typical ratio of registered silver to deliveries. Meanwhile the bleed continues and JP Morgan has no answer or tourniquet.

The long story can be read in the links below.

 [https://twitter.com/Ditch\_DeepState/](https://twitter.com/Ditch_DeepState/status/1395472838426087425)

Here's the rampage report:

https://preview.redd.it/8yjpmh4wyc071.png?width=711&format=png&auto=webp&s=386d20dc747fcfba9693e9d2dfdf251fe13f7dbd

 And here is the guy with empty saddle bags ... all zeros there! 

&#x200B;

https://preview.redd.it/vz8u6la1zc071.png?width=797&format=png&auto=webp&s=069b9d4642fdde31437316f08ce505f8a7db7b4c

 The end is in sight!!!

 I really never thought this would happen in 2021. 

Together with transitory inflation and comex draining silver price may reach over triple digit  levels  within 2021 . 

This is not financial advice .",nhelw3,[],0
9582,2021-05-20,wallstreetbets,"Michael Burry being short TSLA at a perfect time. 

read this: [https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/](https://insideevs.com/news/507467/tesla-modelx-deliveries-pushed-october/). 

I have a back ordered Model X and a pissed wife with a baby ape growing inside of her. She's do in July, car was supposed to deliver June, instead they are telling me Oct - now I am hearing Feb 2022. 

I spoke to a sales rep at Tesla she says they haven't delivered any Model X or S this year and she doesn't think they will. TSLA is really effected by the chip shortage, orders from Dec. were promised Mar. & now they aren't expected till Oct and may be pushed back over all to 2022. Orders are being canceled, and you even have UFC fighters calling them out [https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/](https://www.teslarati.com/tesla-elon-musk-beneil-dariush-ufc-model-3-loaner/) 

TBH I am just pissed Dariush gets a loaner and I don't, so I have decided to go about it my own way. I have puts and I am going to buy more puts tomorrow and hold it until it makes me enough money to buy my car cash. 

Support my vision fellow apes. 

&#x200B;

https://preview.redd.it/bi2zytp43d071.jpg?width=1739&format=pjpg&auto=webp&s=dfbf8869d0f26647b6aa362e7d0d46a14896402d

https://preview.redd.it/4d3qmeq43d071.jpg?width=1732&format=pjpg&auto=webp&s=2fccaf1d930655ad529b2f43c9e20baa9cd6f6e2",nhexk4,[],0
9585,2021-05-21,wallstreetbets,"# SPY 5/20 Recap

https://preview.redd.it/p3laz9p1yc071.png?width=1427&format=png&auto=webp&s=c983f43c547ee4f7a49381a5f0509320922f97cf

* Filled gap convincely.
* Hit resistance ðŸŽ¯ but not bullish ðŸŽ¯s. Reached high of 416.63 or 0.18 from first bullish pt from this mornings read. 
* Spiked @ 86 ish on RSI and ended the day @ 52 ish (Bullish). 15 min. timeframe.   

https://preview.redd.it/06xx2qw5oc071.png?width=2163&format=png&auto=webp&s=6a63a6a9790d4c0e2de234447c8eedb72ac5071d

# 15 min. RSI

https://preview.redd.it/jq7spgkbpc071.png?width=2163&format=png&auto=webp&s=52f94f11a879a2a3b68b5d26656d0f566d5bdeb4

[From post this morning:](https://www.reddit.com/r/wallstreetbets/comments/ngzlre/i_spy_520_read/)

https://preview.redd.it/cisrmbfjpc071.png?width=4104&format=png&auto=webp&s=4df655407d320ad425dd7f314a4ca11228dbb8d5

# W-Shape Recovery?

[Outlook post from last night.](https://www.reddit.com/r/wallstreetbets/comments/ngglg9/i_spy_519_recap_and_520_outlook/)

[outlook post from last night](https://preview.redd.it/3jqflwh9qc071.png?width=2468&format=png&auto=webp&s=e36443442cb090f0598fe727d8911f80fc3be7d0)

W-shape with today's price action. 

* For the w-shape to hold true we need to push over 418. 

https://preview.redd.it/3wbsfzmypc071.png?width=2163&format=png&auto=webp&s=140453b61e599b3d2c0ff80256b7bfecf66b6df7

# 5/21 Outlook - Bullish - Neutral

* Bulls need to fill the gap on the 1D timeframe. Gap fill is at 416.72 - 418
* If Bulls find support at 418 then I believe that we hit the call wall at 419-420 - 420.53
* Best case for bulls is that we gap above and test new support @ 418. 
* Bears need to protect gap. If gap is tested and resistance holds look for 415 - 414 - 412 (gap fill) - 410. I don't think we see below 410 but we shall see.   

https://preview.redd.it/6ov1jlqo0d071.png?width=2163&format=png&auto=webp&s=56f210c9a4f919956e487420ad29fa05a4db6afe

1D RSI

* RSI at 53ish (>50 = bullish)

https://preview.redd.it/4elq6ug15d071.png?width=2163&format=png&auto=webp&s=d100f916882cc35b1142bb6e4a805cb2a684e4a2

SPY [SPOT GAMMA](https://spotgamma.com/) \- Tomorrow's data is incomplete. 

https://preview.redd.it/qhxhmwhyrc071.png?width=2648&format=png&auto=webp&s=163d1435b058a1a2fb595268a1760196e55d95e7

Look for 5/21 SPY read post tomorrow morning before open. 

Thanks for reading!

Night\_Man",nhf742,[],1
9591,2021-05-21,wallstreetbets,"I have discovered the truth amongst the stars. 

May 26 2019 NYT posted an article about a UFO sighting. Spy proceeds to sell off for 4+ days. 283-273

April 29 2020 CNN post a massive UFO article. It is filled with classified UFO reports and sighting.

SPY drops from 291-279 over the course of 4 days.

May 16 2021 60 minutes posts a revealing article of our alien overlords. Spy drops from 415-405 over the course of 4 DAYS! 


This leads me to believe that SPY is being manipulated by ALIENS! 


Pencils FUCKING DOWN! Tinfoil hats off!

This is not financial advice. I have been drinking margaritas. I am not being probbed at least to my knowledge.

Spy puts next pentagon UFO leak!",nhgr70,[],0
9600,2021-05-21,wallstreetbets,"So I went down the rabbit hole a while back after being a meme stock bear.  Mind blown. All I have to say is watch Wes Christian. I had been trading for a decade and you apes opened this world up to me.  

However I was deep thinking, so I started digging.  We never recovered from the 08 crisis.  They just dropped interest rates and turned on the printer.  

Now in 11-12 I was a security guard for a company that made coins for the us mint/ tiff jewelry.  Gold was crazy 16-1700$ an once.  Itâ€™s gone up 150-200$ an oz in the decade where we printed more money than we have since our founding. 

What if the government knew they were fucked and told hedge funds to naked short everything till oblivion. 


Hear me out, you naked short bonds, stocks and precious metals on paper. Like diluing the silver paper market and wal lah you drive the silver market to the ground which effects the price of actual silver.  You now control inflation or anything. 

Where does this leave us? In a market where everything is fake that 25$ an once silver you bought is actually worth 100$ because for every legit oz on the market thereâ€™s at least 4x the oz that are sold are synthetic. No rules for short sellers. 

What if the government gave the green light to the short sellers to do what they do and dilute so the masses love the government for free money but at the same time keep inflation under control.  Short the market so that we donâ€™t have to answer for the fact we never recovered from the 08 crash and never raised interest rates.  

Apes look up academic papers from the 08 collapse and whatâ€™s going on now naked shorting is on the rise.  

Itâ€™s nuts

Call/ email https://www.nasaa.org they are your state regulators.  (State police of fraud)They will help bunch of small town sheriffs/ investigators just trying to make a name for themselves.  From there itâ€™ll be up to the local politicians for action.",nhimlx,[],0
9601,2021-05-21,wallstreetbets,"You guys must be, and forgive me for using such an awful term, bit you must be RETARDS.  


P/E of 8.9???? 
Short 25% of float?????
You guys are smoking the gange and wearing your ridiculous parachute pants and EYELINER and otherwise being fools worse than even apes.  

Wake up!  Get your guns (At Academy)!!! Social unrest will not settle out and if it does people will play soccer anyway.  

All I'm saying you friggin whippersnappers is that this will happen....

I'm pretty sure anyway.  

I don't have May calls either before I get called a hedgey again. 

I have June. 

If it just balances with Dicks it goes to $53.
If it squeezes it will be $80


Look up its book value.  

Look it up on Stock twits.

Big boys are playing it to keep calls from being exercised. I'm telling you.

Sell your TSLA before it's too late and get in.",nhimy5,[],0
9603,2021-05-21,wallstreetbets,"This happened roughly 4 hours ago from making this post and the new terms go into effect June 1st. 

I really think this is huge for GOOG/GOOGL ad revenue. According to socialblade, there are 56 million channels under 1k subs(10-999) as of November 13 2020. Youtube previously demonetized smaller channels but I guess is going all in.

From Youtube: ""YouTubeâ€™s right to monetize: YouTube has the right to monetize all content on the platform and ads may appear on videos from channels not in the YouTubeÂ PartnerÂ Program.""

With GOOG's stock rising $600 EPS over the past 6 months and with this, I almost see nothing that can stop tremendous ad revenue and a moderate EPS during Q3 earnings call.",nhj72c,[],0
9605,2021-05-21,wallstreetbets,"If you're still kicking yourself about not putting your entire 401k into Shopify and getting those sweet 40x gains, I think BIGC may be one of the next hot stocks.

Currently BIGC is trading at 17x revenue and I think that a fair value for this stock is 20 to 40x revenue (especially since it will be compared with Shopify). Average growth the past few years per quarter is around 8.4% per quarter.

Currently the stock is down this year trading around $50, peak was $140 last year.

Projecting out growth over 5 years shows that:

1. 2021: Revenue $211M, stock $60 to $120
2. 2022: Revenue $292M, stock $83 to $166
3. 2023: Revenue $403M, stock $114 to $230
4. 2024: Revenue $556M, stock $158 to $316
5. 2025: Revenue $768M, stock $218 to $437
6. 2026: Revenue $1B, stock $302 to $604

Personally I think that as the company continues to show strong growth the share price will grow overvalued in the short term (before EOY). I do think the stock will be a 5 to 10x bagger in the next five years though. They may also be able to hit $1B in revenue sooner than 2026.

TLDR; BIGC good, like SHOP, but undervalued.

Position: 2000 shares @ $55

>!(research is my own and might be garbage. never take advice from strangers)!<",nhjghj,[],1
9612,2021-05-21,wallstreetbets,"This is a web based business, yet they make it impossible to send them an ACH. Even after the account is verified, there appears to be no way to actually send them money. It's as if they hate cash, and want it to stay far away from them.

The help documents have no instructions as to how to actually accomplish this.

Furthermore their support contact is broken, after several attempts I gave up. There is also no phone contact which can reach an actual human. 

The coinbase reddit page autoblocked my post there. The only other support option is twitter, there is no way in hell I'm doing that.

TLDR; broken website, no support",nhjzjh,[],0
9708,2021-05-20,wallstreetbets,"So just how big is **today's news about the initial success of the Sofusa technology**?

1st, this is a technology that aims at lymphatic delivery. 

**What does this mean?** Well, when trying to fight a disease, it's difficult to target the lymphatic system. Because of how it works and the fact that it is spread throughout our body. 

So there are MANY, MANY drugs out there that treat several conditions through the lymphatic system. But, because of what we just explained, those drugs sometimes don't work. They are not properly ""delivered"". They don't get to where they need to get to make the necessary interaction and solve the problem.

**Sorrento has developed a technology that can deliver drugs to where they actually need to go** in the lymphatic system. So this is definitely breakthrough technology. Other companies are aiming to find similar solutions. But we are definitely talking about very advanced bio-tech.

In this case, we have a patient suffering from rheumatoid arthritis. This is a condition that worsens with time. It's very painful and limits the patient's movement. It's not very common, so we are talking about 1.5 million people in the USA and about 30 million worldwide. 

But remember, **the technology Sorrento is developing  will be able to deliver drugs treating many other diseases** related to the lymphatic system. So the market for Sofusa is very, very large.

The press release tells us Sofusa was tested on ""First Enbrel-Non-Responding"" patients. 

**What does this mean?** Patients who need the drug Enbrel and, even though they have not been taking the drug for long (it's a ""first"" for them) they are not responding to it. It isn't helping them. 

Now, Sofusa comes into play. It's job is to deliver Enbrel to the patient effectively. To ""take"" Enbrel to where it needs to go in the lymphatic system.. 

The 1st obvious advantage is that the drug wasn't helping and now helps. But there are other important advantages.

Since the drug is being carried to its targeted ""destination"" the dosage needed, diminishes. Because less is ""lost along the way"". This is important because many diseases related to the lymphatic system, such as rheumatoid arthritis, are chronic, lifelong conditions. Being able to administer less drugs really helps the patient. Now you have a drug that actually works, more potently, which reduces its dosage. All this thanks to Sorrento.

The press release points out an important factor: This is a trial on ONE type of drug/treatment. Other such trials testing the effectiveness of Sofusa are already taking place. Again, this is proof of the potentially huge market for this delivery system.

Just to get an idea, the release mentions anti-PD1 and anti-CTLA4 antibodies. These are a type of drugs that inhibit the activity of certain proteins (they inhibit PD1 and CTLA4, which are types of proteins. By stopping their activity, they help in stopping the growth of cancer tumors). There are several drugs that fall under these categories and treat a wide variety of cancers. **Sofusa can potentially play a vital role in all these treatments**. 

This is like several companies developing apps while Sorrento is developing a new smartphone technology. Each app has its rightful use and market. But once the new smartphone is up and working, all apps will need it. So this technology has huge revenue implications. T**he fact we are hearing good news about it is HUGE**.

As for the results themselves: **The DAS28 test measures rheumatoid activity in 28 joints** in the patient's body. The joints might be swollen or tender (hurting).

This patient had a DAS28 score of 4.6, with 18 out of 28 joints compromised.  That is considered  moderate to high disease activity.  There are 4 levels of DAS 28 scores going from remission (the best) to high (the worst). So this patient was not in the worst shape going in, but pretty bad.

Using Sofusa to deliver the Enbrel drug, in just 4 weeks (this is a very short time for this type of disease!!) the results went from 4.6 to 3.0. The total amount of compromised joints, from 18 to 11. **That is a dramatic change**. The patient went from being somewhere between level 3 and 4, to being in the lower level 2, called ""low disease activity"", which indicates it's moving towards remission (the lowest level). For someone suffering from this condition, it's a real life changer. For the company selling Enbrel, it's a real market changer. And if it can equally help people with tumors, **Sofusa becomes a major therapeutic factor.** 

I hope investors understand this. **It's another major development in an already extremely promising pipeline** which is currently badly undervalued. If the price doesn't spike today by 10-15%, as it should, just from this news, it would be disappointing. 

But if you are long, today's price change isn't what matters the most. Itâ€™s the understanding that Sorrento / SRNE has ANOTHER ace in its hand!",ngulnq,[],1
